USRE32947E - Magnetic transcutaneous mount for external device of an associated implant - Google Patents
Magnetic transcutaneous mount for external device of an associated implant Download PDFInfo
- Publication number
- USRE32947E USRE32947E US07/144,011 US14401188A USRE32947E US RE32947 E USRE32947 E US RE32947E US 14401188 A US14401188 A US 14401188A US RE32947 E USRE32947 E US RE32947E
- Authority
- US
- United States
- Prior art keywords
- rare
- magnet
- iaddend
- iadd
- coil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/375—Constructional arrangements, e.g. casings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
- A61N1/37223—Circuits for electromagnetic coupling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0001—Means for transferring electromagnetic energy to implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36036—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of the outer, middle or inner ear
- A61N1/36038—Cochlear stimulation
Definitions
- This invention relates generally to apparatus for coupling a member implanted in a body with a member located outside the body. More particularly, but not by way of limitation, the invention relates to a bio-electronic signal coupling device (such as a hearing aid having a cochlear implant unit and a sound receiving unit) utilizing rare-earth magnets to properly align and secure an external member (such as the sound receiving unit) with an internal member (such as the cochlear implant unit).
- a bio-electronic signal coupling device such as a hearing aid having a cochlear implant unit and a sound receiving unit
- rare-earth magnets to properly align and secure an external member (such as the sound receiving unit) with an internal member (such as the cochlear implant unit).
- a hearing aid known as an auditory neural prosthesis is used to electrically stimulate a user's auditory nerve directly or within the cochlea thereby to enable recognition of environmental sounds and to improve lip-reading skills.
- a prosthesis includes an internal, subcutaneously located signal receiving unit implanted in the user so that an electrical signal can be conducted to a cochlea of the user.
- the prosthesis also includes an external sound detecting and transmitting unit located outside the skin of the user.
- the sound detecting and transmitting unit For the sound detecting and transmitting unit to effectively transmit to the receiving unit electrical signals corresponding to the detected sounds, the sound detecting and transmitting unit must be maintained in proper alignment with the receiving unit.
- Presently proposed or used devices attempt to maintain alignment by utilizing eyeglass frames specially constructed to carry the sound detecting and transmitting unit. This frame structure has the shortcoming of permitting misalignment between the external and internal units because the eyeglass frames can slip and otherwise become easily moved. Such misalignment decreases, if not totally eliminates, the amplitude of the coupled signal received by the receiving unit. This decrease or loss of signal results in decreased or lost cochlea stimulation which causes frustration in the user of the apparatus because he or she has to continually readjust the eyeglass frames to maintain the apparatus operative. This misalignment also hampers the training, evaluation and use of the prosthesis user.
- the reliability of such multi-channel devices would be greatly decreased because accurate alignment is critical to insure that each of the plurality of signals transmitted by the transmitter means in the multi-channel transmitter unit is received by the proper receiver means in the implanted multi-channel receiving unit.
- the present invention overcomes the above-noted and other shortcomings of the prior art by providing a novel and improved medical apparatus coupling device.
- This apparatus maintains in proper alignment or desired positional securement a unit which is disposed beneath the surface of the skin of a user and a unit located outside the surface of the user's skin. Furthermore, there is no mechanical connection extending through the user's skin to maintain this alignment. Additionally, this present invention has no known significantly adverse effect on the user's skin extending between the internally located unit and the externally positioned unit.
- the present invention provides a transcutaneous coupling apparatus comprising a first member positioned subcutaneously, a second member positioned supercutaneously (i.e., outside the skin), and magnet means for magnetically securing the second member to the first member.
- the first member includes in preferred embodiments electronic means which can receive an electrical signal or transmit an electrical signal or perform both functions.
- the second member includes in a first embodiment means for transmitting the electrical signal to the receiving first member or in another embodiment includes electronic means for receiving the electronic signal transmitted by the first member.
- the second member can include means for performing both receiving and transmitting functions.
- the transcutaneous coupling apparatus is a bio-electronic signal coupling device for maintaining a desired positional relationship between the first and second members so that the proper transmitting and receiving between the members can occur.
- the first member specifically includes a first electrically conductive coil having two ends, each of which is embedded in tissue of the user of the apparatus.
- the second member in such an embodiment includes a second electrically conductive coil and signal generating means, electrically connected to the second coil, for providing an electrical signal to the second coil so that the signal is transferred by electromagnetic induction transcutaneously to the first coil for electrically stimulating the tissue in which the ends of the first coil are embedded.
- the magnet means generally includes a rare-earth element. More particularly, the magnet means includes a first rare-earth magnet associated with the first coil of an embodiment of the first member, and the magnet means also includes a second rare-earth magnet associated with the second coil of an embodiment of the second member, for magnetically coupling with the first rare-earth magnet so that the first and second coils are positioned to achieve electromagnetically inductive coupling. To maintain the first and second members in a predetermined relation, the magnet means further includes a third rare-earth magnet associated with the first coil and a fourth rare-earth magnet, associated with the second coil, for magnetically coupling with the third rare-earth magnet.
- the third and fourth magnets have as their attractive polarities magnetic poles of opposite polarities to the attractive polarities of the first and second magnets so that each of the magnets on the first member will be attracted to only one of the magnets located on the second member.
- FIG. 1 is a schematic illustration and block diagram of a preferred embodiment of the present invention.
- FIG. 2 is a sectional side elevational view of a coil assembly of the preferred embodiment of the present invention.
- FIG. 3 is an end elevational view of the coil assembly shown in FIG. 2.
- FIG. 4 is a schematic and block diagram of the electronic elements of the preferred embodiment of the present invention.
- FIG. 5 is a sectional side elevational view of a coil assembly of a second preferred embodiment of the present invention.
- FIG. 6 is a block diagram of another preferred embodiment of the present invention. .Iaddend.
- the medical apparatus coupling device of the present invention provides transcutaneous coupling of a subcutaneously located first member with a supercutaneously (i.e., outside the skin) positioned second member.
- a bio-electronic signal coupling device which assists the hearing of a user of the device.
- the signal coupling device is particularly a hearing aid 2 schematically illustrated by the block diagram shown in FIG. 1.
- the hearing aid 2 includes an internal first member 4 which is designated in FIG. 1 as an internal coil assembly 6.
- the internal coil assembly 6 is a cochlear implant unit containing electronic receiver means for receiving a transmitted signal.
- the internal coil assembly 6 can include means for transmitting a signal or means for both receiving and transmitting signals. .Iadd.See, for example, transmitter 48 depicted in FIG. 6. .Iaddend.Units other than signal receiving or transmitting ones can also comprise the first member.
- the internal coil assembly 6 is subcutaneously located beneath a layer of tissue 8 which includes the epidermal and dermal layers of the skin of the user of the device when the device is the preferred embodiment hearing aid 2.
- FIGS. 2 and 4 disclose that the internal coil assembly 6 includes a first electrically conductive coil 10 of wire having two ends embedded in subcutaneous tissue. Specifically, as shown in FIG. 4 a first end or electrode 12 of the coil 10 is inserted in a cochlea of the user and a second end or electrode 14 is inserted in adjacent tissue as a reference electrode.
- the first coil 10 comprises six hundred turns of 40 AWG copper wire. This wire is wound on a first support member 16 comprising a delrin bobbin 18 placed in a ceramic, pot-type core-half 20.
- the core-half 20 preferably has a right circular cylindrical shape because a hole having a complementary shape can be readily cut with a circular trephine into the bone in which the internal core assembly 6 is to be inserted.
- the present invention includes a second member 22 which in the preferred embodiment includes signal generating and transmitting means 24 located supercutaneously of the user of the invention.
- FIG. 1 reveals the means 24 includes a sound detector and signal conditioner means 26 and an external coil assembly 28. .Iadd.In the preferred embodiment depicted in FIG. 6, the second member includes a receiver 50. .Iaddend.
- the external coil assembly 28 includes a second electrically conductive coil 29.
- the second coil 29 includes four hundred turns of 38 AWG copper wire wound on a second support member comprising a delrin bobbin and a ceramic, pot-type core-half similar to the bobbin 18 and core-half 20 shown in FIG. 2 constituting the internal coil assembly 6.
- the sound detector and signal conditioner 26 is electrically connected to the second electrically conductive coil 29 and generates an electrical signal which is electromagnetically transferred transcutaneously by the second coil 29 to the first coil 10 for electrically stimulating the subcutaneous tissue (specifically, the cochlea) in which the electrodes 12 and 14 of the first coil 10 are embedded.
- FIG. 4 shows the sound detector and signal conditioner means 26 includes a transducer, specifically a microphone 30, for detecting a sound and converting it into a proportional electrical signal.
- the proportional electrical signal is amplified by amplifier means 32 and input into amplitude modulation circuit means 34.
- the amplitude modulation circuit means 34 utilizes the amplified electrical signal to modulate a carrier signal which is generated by carrier frequency generator means 36.
- the carrier frequency generator means 36 provides a 16 kHz carrier signal which is amplitude modulated by the electrical signal coming from the amplifier means 32.
- the resultant amplitude modulated signal is provided to the second coil 29 for electromagnetic transmission transcutaneously through the intervening tissue 8 to the first coil 10.
- the microphone 30, amplifier means 32, amplitude modulation circuit means 34 and carrier frequency generator means 36 depicted in FIG. 4 are of the type as are known in the art.
- the magnet means electromagnetically associates the receiver means provided by the preferred embodiment internal coil assembly 6 with the transmitter means provided by the preferred embodiment means 24 so that the first coil 10 of the receiver means is responsive to the transmitted electrical signal transmitted by the second coil 29 of the preferred embodiment transmitter means.
- the magnet means comprising two magnets 52, 54, magnetically secures the transmitter 48 and the receiver 50. .Iaddend.
- the magnet means include a rare-earth element which is particularly a first rare-earth magnet 38 associated with the first coil 10 by being concentrically positioned therewith in the pot-type core-half 20.
- the rare-earth element included within the magnet means may be any appropriate one of the group of chemical elements including atomic numbers between 58 and 71.
- the rare-earth element is samarium which is combined with cobalt to provide a samarium-cobalt magnet (e.g., SmCo 5 ) having a long magnetic stability and a large maximum energy product.
- first rare-earth magnet 38 forming a part of the magnet means of the present invention
- a second rare-earth magnet associated with the second coil 29 of the second member 22 for magnetically coupling with the first rare-earth magnet 38 so that the first and second coils 10 and 29 are positioned for electromagnetically inductive coupling.
- the magnetic coupling arises by placing attractive poles of the first and second magnets toward each other so that the magnetic lines of force extend through the intervening tissue 8 to retain the internal and external coil assemblies in alignment adjacent the intervening skin.
- the magnetic north pole of the first rare-earth magnet 38 can be positioned within the first member 4 (specifically, within the core-half 20) so that it lies closer to the second member 22 (specifically, the core-half of the external coil assembly 28) than does the magnetic south pole of the first magnet 38.
- This positioning of the first magnet 38 requires that the magnetic south pole of the second rare-earth magnet be positioned in the second member 22 so that it will magnetically couple with the magnetic north pole of the first magnet when the second member 22 is placed to properly position the second coil 29 relative to the first coil 10.
- the first member 4 containing the first rare-earth magnet 38 is subcutaneously implanted in the user of the apparatus.
- the electrodes 12 and 14 of the first coil 10 are implanted in the respective locations previously described.
- the second member 22, having the second rare-earth magnet associated therewith is positioned supercutaneously adjacent the outer surface of the user's skin so that the first and second magnets magnetically secure themselves together thereby properly positioning the first and second coils 10 and 29 for maximum signal transference from the second member 22 to the first member 4.
- the signal which is to be transferred from the second member 22 to the first member 4 is obtained by using the transducer or microphone 30 to detect an ambient sound and converting it into a proportional electrical signal, amplifying this signal, and amplitude modulating with this amplified signal the 16 kHz carrier signal generated by the carrier frequency generator means 36.
- the amplitude modulated signal is transferred to the second coil 29 of the second member 22 for electromagnetically inductive coupling with the first coil 10 of the first member 4.
- the electromagnetically induced signal received by the first coil 10 is impressed across the reference tissue and cochlea tissue to which the electrodes of the first coil are embedded. This electrical stimulation of the cochlea enhances the hearing and lip-reading skills of the user.
- the previously described type of system utilizing the single first coil 10 and the single second coil 29 is known as a single-channel hearing aid because only a single signal is transferred to the user of the apparatus at any one time.
- multi-channel devices which are being developed for simultaneously transferring a plurality of signals to permit frequency coding and subsequent frequency analysis of the detected sounds.
- it is necessary to accurately align the respective transmitting and receiving channels comprising, for example, a plurality of coils similar to those shown in the drawings.
- the initial alignment and subsequent maintenance of the alignment would be difficult using the preferred embodiment shown in FIGS. 1--4 because with only a single pair of magnets, the first member and second members could rotate whereby respective channels could become misaligned.
- FIG. 5 a plurality of magnets forming a multiple number of magnet pairs can be used as shown in a second preferred embodiment illustrated in FIG. 5. It is to be noted that although the FIG. 5 embodiment is of the single-channel type, it could readily be adapted to a multi-channel type.
- the FIG. 5 embodiment discloses a support member 40 and coil assembly 42 similar to that shown in FIGS. 2 and 3.
- the magnet means of the FIG. 5 embodiment is different from that shown in FIG. 2 because two rare-earth magnets are disposed in the support member 40 of FIG. 5.
- a first rare-earth magnet 44 is magnetically coupled with a second rare-earth magnet (not shown) which is properly situated in a second member which is similar to the second member 22.
- a third rare-earth magnet 46 shown in FIG. 5 is paired with a fourth rare-earth magnet (not shown) which is properly situated in the second member of the second preferred embodiment. Therefore, the magnets are grouped in attractive magnetic relation between the receiver and transmitter means of the first and second members, respectively.
- the second member could be magnetically coupled to the first member in either of two directions.
- the first and second members could be positively related so that either the first and second magnets and the third and fourth magnets were magnetically coupled or the first and fourth magnets and the second and third magnets were magnetically coupled.
- the first and third rare-earth magnets 44 and 46 can be disposed in the first member so that the two polarities facing the second member are opposite.
- the first magnet could have its magnetic north pole disposed for coupling with the second member and the third magnet could have its magnetic south pole disposed for coupling with the second member.
- the second magnet could be disposed in the second member so that its magnetic south pole is disposed for coupling with the first member and the third magnet could be disposed in the second member so that its magnetic north pole is disposed for coupling with the first member.
- the first and second members can only be magnetically coupled in a single alignment because coupling will occur only when the first magnet and second magnet are aligned and the third magnet and fourth magnet are aligned.
- the reverse alignment of the magnets of the first and second members results in similar poles facing each other thereby causing a repulsive force.
- the third and fourth magnets have as their attractive polarities magnetic poles of opposite polarities to the attractive polarities of the first and second magnets, respectively.
- the present invention contemplates any medical apparatus having a first member implanted below the surface of the skin of the user and having a second member located externally to the user's skin but transcutaneously coupled to the first member.
- hearing aid as used herein is not limited to those devices which amplify sounds, but rather is intended to encompass all suitable devices which assist one in hearing and/or comprehending sound.
Abstract
Disclosed is a transcutaneous coupling apparatus comprising a first member subcutaneously positioned in a user of the invention and also comprising a second member positioned supercutaneously, or outside the skin of the user. Rare-earth magnets are associated with the first and second members to magnetically secure the second member with the first member without significantly adversely affecting the user's skin intervening between the first and second members.
Description
This invention relates generally to apparatus for coupling a member implanted in a body with a member located outside the body. More particularly, but not by way of limitation, the invention relates to a bio-electronic signal coupling device (such as a hearing aid having a cochlear implant unit and a sound receiving unit) utilizing rare-earth magnets to properly align and secure an external member (such as the sound receiving unit) with an internal member (such as the cochlear implant unit).
In the medical implantable electronic prosthesis field it is necessary to maintain proper alignment between units implanted within the body and units associated therewith but located externally of the body. Specifically, in medical prostheses involving electrical signal transfers, such as hearing aids, it is critical to maintain a proper alignment between the implanted and external units to insure effective signal transfer.
For example, a hearing aid known as an auditory neural prosthesis is used to electrically stimulate a user's auditory nerve directly or within the cochlea thereby to enable recognition of environmental sounds and to improve lip-reading skills. Such a prosthesis includes an internal, subcutaneously located signal receiving unit implanted in the user so that an electrical signal can be conducted to a cochlea of the user. The prosthesis also includes an external sound detecting and transmitting unit located outside the skin of the user.
For the sound detecting and transmitting unit to effectively transmit to the receiving unit electrical signals corresponding to the detected sounds, the sound detecting and transmitting unit must be maintained in proper alignment with the receiving unit. Presently proposed or used devices attempt to maintain alignment by utilizing eyeglass frames specially constructed to carry the sound detecting and transmitting unit. This frame structure has the shortcoming of permitting misalignment between the external and internal units because the eyeglass frames can slip and otherwise become easily moved. Such misalignment decreases, if not totally eliminates, the amplitude of the coupled signal received by the receiving unit. This decrease or loss of signal results in decreased or lost cochlea stimulation which causes frustration in the user of the apparatus because he or she has to continually readjust the eyeglass frames to maintain the apparatus operative. This misalignment also hampers the training, evaluation and use of the prosthesis user.
If the eyeglass frame structure were used with multichannel auditory neural prostheses which are being developed to provide frequency coding of detected sounds, the reliability of such multi-channel devices would be greatly decreased because accurate alignment is critical to insure that each of the plurality of signals transmitted by the transmitter means in the multi-channel transmitter unit is received by the proper receiver means in the implanted multi-channel receiving unit.
Although proper alignment must be maintained in medical apparatus having units located both beneath the surface of the skin and above the skin, it is desirable that there be no mechanical connection which extends through the skin of the user between the internal and external units. Although no mechanical connection, which could rigidly maintain a predetermined distance between the internal and external units so that no compression of the intervening skin occurred, is wanted, neither is there desired a coupling device which adversely affects, such as by compression, the skin extending between the implanted unit and the external unit. Therefore, what is desired is an apparatus which secures the external unit with the internal unit without adversely affecting the intervening tissue.
Although there have been proposed and made medical apparatus having implantable units and external units which need to be coupled or held in alignment by some means, such as the aforementioned type of hearing aid using an eyeglass frame, we do not know of any such apparatus which discloses or suggests our invention as disclosed and claimed hereinbelow.
The present invention overcomes the above-noted and other shortcomings of the prior art by providing a novel and improved medical apparatus coupling device. This apparatus maintains in proper alignment or desired positional securement a unit which is disposed beneath the surface of the skin of a user and a unit located outside the surface of the user's skin. Furthermore, there is no mechanical connection extending through the user's skin to maintain this alignment. Additionally, this present invention has no known significantly adverse effect on the user's skin extending between the internally located unit and the externally positioned unit.
Broadly, the present invention provides a transcutaneous coupling apparatus comprising a first member positioned subcutaneously, a second member positioned supercutaneously (i.e., outside the skin), and magnet means for magnetically securing the second member to the first member.
The first member includes in preferred embodiments electronic means which can receive an electrical signal or transmit an electrical signal or perform both functions. Likewise, the second member includes in a first embodiment means for transmitting the electrical signal to the receiving first member or in another embodiment includes electronic means for receiving the electronic signal transmitted by the first member. Alternatively, the second member can include means for performing both receiving and transmitting functions.
When the first and second members specifically include receiving and transmitting means, respectively, the transcutaneous coupling apparatus is a bio-electronic signal coupling device for maintaining a desired positional relationship between the first and second members so that the proper transmitting and receiving between the members can occur. In such an embodiment the first member specifically includes a first electrically conductive coil having two ends, each of which is embedded in tissue of the user of the apparatus. The second member in such an embodiment includes a second electrically conductive coil and signal generating means, electrically connected to the second coil, for providing an electrical signal to the second coil so that the signal is transferred by electromagnetic induction transcutaneously to the first coil for electrically stimulating the tissue in which the ends of the first coil are embedded.
The magnet means generally includes a rare-earth element. More particularly, the magnet means includes a first rare-earth magnet associated with the first coil of an embodiment of the first member, and the magnet means also includes a second rare-earth magnet associated with the second coil of an embodiment of the second member, for magnetically coupling with the first rare-earth magnet so that the first and second coils are positioned to achieve electromagnetically inductive coupling. To maintain the first and second members in a predetermined relation, the magnet means further includes a third rare-earth magnet associated with the first coil and a fourth rare-earth magnet, associated with the second coil, for magnetically coupling with the third rare-earth magnet. To achieve the predetermined alignment, the third and fourth magnets have as their attractive polarities magnetic poles of opposite polarities to the attractive polarities of the first and second magnets so that each of the magnets on the first member will be attracted to only one of the magnets located on the second member.
From the foregoing it is a general object of the present invention to provide a novel and improved medical apparatus coupling device. Other and further objects, features and advantages of the present invention will be readily apparent to those skilled in the art when the following description of the preferred embodiments is read in conjunction with the accompanying drawings.
FIG. 1 is a schematic illustration and block diagram of a preferred embodiment of the present invention.
FIG. 2 is a sectional side elevational view of a coil assembly of the preferred embodiment of the present invention.
FIG. 3 is an end elevational view of the coil assembly shown in FIG. 2.
FIG. 4 is a schematic and block diagram of the electronic elements of the preferred embodiment of the present invention.
FIG. 5 is a sectional side elevational view of a coil assembly of a second preferred embodiment of the present invention.
.Iadd.FIG. 6 is a block diagram of another preferred embodiment of the present invention. .Iaddend.
The medical apparatus coupling device of the present invention provides transcutaneous coupling of a subcutaneously located first member with a supercutaneously (i.e., outside the skin) positioned second member. To describe this invention, specific reference will be made to preferred embodiments of a bio-electronic signal coupling device which assists the hearing of a user of the device. The signal coupling device is particularly a hearing aid 2 schematically illustrated by the block diagram shown in FIG. 1.
The hearing aid 2 includes an internal first member 4 which is designated in FIG. 1 as an internal coil assembly 6. In the preferred embodiment the internal coil assembly 6 is a cochlear implant unit containing electronic receiver means for receiving a transmitted signal. However, it is to be noted that in other embodiments the internal coil assembly 6 can include means for transmitting a signal or means for both receiving and transmitting signals. .Iadd.See, for example, transmitter 48 depicted in FIG. 6. .Iaddend.Units other than signal receiving or transmitting ones can also comprise the first member.
The internal coil assembly 6 is subcutaneously located beneath a layer of tissue 8 which includes the epidermal and dermal layers of the skin of the user of the device when the device is the preferred embodiment hearing aid 2. FIGS. 2 and 4 disclose that the internal coil assembly 6 includes a first electrically conductive coil 10 of wire having two ends embedded in subcutaneous tissue. Specifically, as shown in FIG. 4 a first end or electrode 12 of the coil 10 is inserted in a cochlea of the user and a second end or electrode 14 is inserted in adjacent tissue as a reference electrode. In the preferred embodiment the first coil 10 comprises six hundred turns of 40 AWG copper wire. This wire is wound on a first support member 16 comprising a delrin bobbin 18 placed in a ceramic, pot-type core-half 20. The core-half 20 preferably has a right circular cylindrical shape because a hole having a complementary shape can be readily cut with a circular trephine into the bone in which the internal core assembly 6 is to be inserted.
In addition to the first member 4, the present invention includes a second member 22 which in the preferred embodiment includes signal generating and transmitting means 24 located supercutaneously of the user of the invention. FIG. 1 reveals the means 24 includes a sound detector and signal conditioner means 26 and an external coil assembly 28. .Iadd.In the preferred embodiment depicted in FIG. 6, the second member includes a receiver 50. .Iaddend.
The external coil assembly 28 includes a second electrically conductive coil 29. In the preferred embodiment the second coil 29 includes four hundred turns of 38 AWG copper wire wound on a second support member comprising a delrin bobbin and a ceramic, pot-type core-half similar to the bobbin 18 and core-half 20 shown in FIG. 2 constituting the internal coil assembly 6.
The sound detector and signal conditioner 26 is electrically connected to the second electrically conductive coil 29 and generates an electrical signal which is electromagnetically transferred transcutaneously by the second coil 29 to the first coil 10 for electrically stimulating the subcutaneous tissue (specifically, the cochlea) in which the electrodes 12 and 14 of the first coil 10 are embedded. FIG. 4 shows the sound detector and signal conditioner means 26 includes a transducer, specifically a microphone 30, for detecting a sound and converting it into a proportional electrical signal. The proportional electrical signal is amplified by amplifier means 32 and input into amplitude modulation circuit means 34. The amplitude modulation circuit means 34 utilizes the amplified electrical signal to modulate a carrier signal which is generated by carrier frequency generator means 36. In the preferred embodiment the carrier frequency generator means 36 provides a 16 kHz carrier signal which is amplitude modulated by the electrical signal coming from the amplifier means 32. The resultant amplitude modulated signal is provided to the second coil 29 for electromagnetic transmission transcutaneously through the intervening tissue 8 to the first coil 10. The microphone 30, amplifier means 32, amplitude modulation circuit means 34 and carrier frequency generator means 36 depicted in FIG. 4 are of the type as are known in the art.
For the electromagnetically inductive transmission between the first coil 10 and the second coil 29 to be properly achieved, it is necessary to provide means for properly securing the external coil assembly 28 (and the sound detector and signal conditioner means 26 if it is unistructurally combined with the external coil assembly 28) with the internal assembly 6 without significantly adversely affecting the intervening tissue 8. This is achieved in the present invention with magnet means for magnetically securing the second member 22 with the first member 4. The magnet means electromagnetically associates the receiver means provided by the preferred embodiment internal coil assembly 6 with the transmitter means provided by the preferred embodiment means 24 so that the first coil 10 of the receiver means is responsive to the transmitted electrical signal transmitted by the second coil 29 of the preferred embodiment transmitter means. .Iadd.For the FIG. 6 embodiment, the magnet means, comprising two magnets 52, 54, magnetically secures the transmitter 48 and the receiver 50. .Iaddend.
In the preferred embodiment receiver means or internal coil assembly 6 shown in FIG. 2 the magnet means include a rare-earth element which is particularly a first rare-earth magnet 38 associated with the first coil 10 by being concentrically positioned therewith in the pot-type core-half 20. The rare-earth element included within the magnet means may be any appropriate one of the group of chemical elements including atomic numbers between 58 and 71. In the preferred embodiment the rare-earth element is samarium which is combined with cobalt to provide a samarium-cobalt magnet (e.g., SmCo5) having a long magnetic stability and a large maximum energy product.
In addition to the first rare-earth magnet 38 forming a part of the magnet means of the present invention, there is a second rare-earth magnet associated with the second coil 29 of the second member 22 for magnetically coupling with the first rare-earth magnet 38 so that the first and second coils 10 and 29 are positioned for electromagnetically inductive coupling. The magnetic coupling arises by placing attractive poles of the first and second magnets toward each other so that the magnetic lines of force extend through the intervening tissue 8 to retain the internal and external coil assemblies in alignment adjacent the intervening skin. For example, the magnetic north pole of the first rare-earth magnet 38 can be positioned within the first member 4 (specifically, within the core-half 20) so that it lies closer to the second member 22 (specifically, the core-half of the external coil assembly 28) than does the magnetic south pole of the first magnet 38. This positioning of the first magnet 38 requires that the magnetic south pole of the second rare-earth magnet be positioned in the second member 22 so that it will magnetically couple with the magnetic north pole of the first magnet when the second member 22 is placed to properly position the second coil 29 relative to the first coil 10.
To use the preferred embodiment of the present invention depicted in FIGS. 1-4, the first member 4 containing the first rare-earth magnet 38 is subcutaneously implanted in the user of the apparatus. During implantation the electrodes 12 and 14 of the first coil 10 are implanted in the respective locations previously described. Next, the second member 22, having the second rare-earth magnet associated therewith, is positioned supercutaneously adjacent the outer surface of the user's skin so that the first and second magnets magnetically secure themselves together thereby properly positioning the first and second coils 10 and 29 for maximum signal transference from the second member 22 to the first member 4.
The signal which is to be transferred from the second member 22 to the first member 4 is obtained by using the transducer or microphone 30 to detect an ambient sound and converting it into a proportional electrical signal, amplifying this signal, and amplitude modulating with this amplified signal the 16 kHz carrier signal generated by the carrier frequency generator means 36. The amplitude modulated signal is transferred to the second coil 29 of the second member 22 for electromagnetically inductive coupling with the first coil 10 of the first member 4. The electromagnetically induced signal received by the first coil 10 is impressed across the reference tissue and cochlea tissue to which the electrodes of the first coil are embedded. This electrical stimulation of the cochlea enhances the hearing and lip-reading skills of the user.
The previously described type of system utilizing the single first coil 10 and the single second coil 29 is known as a single-channel hearing aid because only a single signal is transferred to the user of the apparatus at any one time. However, there are multi-channel devices which are being developed for simultaneously transferring a plurality of signals to permit frequency coding and subsequent frequency analysis of the detected sounds. To insure the proper operation of such multi-channel devices, it is necessary to accurately align the respective transmitting and receiving channels comprising, for example, a plurality of coils similar to those shown in the drawings. The initial alignment and subsequent maintenance of the alignment would be difficult using the preferred embodiment shown in FIGS. 1--4 because with only a single pair of magnets, the first member and second members could rotate whereby respective channels could become misaligned. To prevent misalignment, a plurality of magnets forming a multiple number of magnet pairs can be used as shown in a second preferred embodiment illustrated in FIG. 5. It is to be noted that although the FIG. 5 embodiment is of the single-channel type, it could readily be adapted to a multi-channel type.
The FIG. 5 embodiment discloses a support member 40 and coil assembly 42 similar to that shown in FIGS. 2 and 3. However, the magnet means of the FIG. 5 embodiment is different from that shown in FIG. 2 because two rare-earth magnets are disposed in the support member 40 of FIG. 5. A first rare-earth magnet 44 is magnetically coupled with a second rare-earth magnet (not shown) which is properly situated in a second member which is similar to the second member 22. A third rare-earth magnet 46 shown in FIG. 5 is paired with a fourth rare-earth magnet (not shown) which is properly situated in the second member of the second preferred embodiment. Therefore, the magnets are grouped in attractive magnetic relation between the receiver and transmitter means of the first and second members, respectively.
It is apparent that through the use of the plurality of magnets depicted in FIG. 5, misalignment is less likely to occur once the first and second members are magnetically coupled. However, it is sometimes necessary to orient the first member with respect to the second member in a single, predetermined alignment.
If the two magnets of the first member shown in FIG. 5 has the same polarity orientation and the two magnets of the second member had the same polarity orientation as between themselves but opposite that of the magnets of the first member, the second member could be magnetically coupled to the first member in either of two directions. For example, if each of the magnets 44 and 46 shown in FIG. 5 has its magnetic north pole facing the second member and each of the magnets in the second member had its magnetic south pole facing the first member, the first and second members could be positively related so that either the first and second magnets and the third and fourth magnets were magnetically coupled or the first and fourth magnets and the second and third magnets were magnetically coupled.
To restrict the alignment between the first and second members to a single predetermined position, the first and third rare- earth magnets 44 and 46 can be disposed in the first member so that the two polarities facing the second member are opposite. For example, the first magnet could have its magnetic north pole disposed for coupling with the second member and the third magnet could have its magnetic south pole disposed for coupling with the second member. To complement this pole placement, the second magnet could be disposed in the second member so that its magnetic south pole is disposed for coupling with the first member and the third magnet could be disposed in the second member so that its magnetic north pole is disposed for coupling with the first member. With such magnetic polarities positioned for coupling the first and second members, the first and second members can only be magnetically coupled in a single alignment because coupling will occur only when the first magnet and second magnet are aligned and the third magnet and fourth magnet are aligned. The reverse alignment of the magnets of the first and second members results in similar poles facing each other thereby causing a repulsive force. This can be more generally stated by saying that the third and fourth magnets have as their attractive polarities magnetic poles of opposite polarities to the attractive polarities of the first and second magnets, respectively.
Although the specific embodiments described above disclose either a single pair of magnetic slugs in the shape of small disks located in the centers of symmetrical pot-type core halves or two such pairs of magnetic slugs, it is to be noted that other configurations are also feasible. For example, a ring magnet disposed along the periphery of the pot-type core-half could be used. Likewise, three disk-shaped magnets could be spaced at 120° intervals around each of the first and second members. Still further, a single magnet could be disposed in either the internal member or the external member and a magnetically attractive material, such as a ferromagnetic material, could be placed in the other member so that the attractive material is held in alignment by the single magnet. Other forms of magnet means can likewise be used and yet remain within the scope of the present invention.
It is also to be noted that although the preferred embodiment of the present invention was described with reference to a bio-electronic signal coupling device (more particularly, a hearing aid), the present invention contemplates any medical apparatus having a first member implanted below the surface of the skin of the user and having a second member located externally to the user's skin but transcutaneously coupled to the first member.
Still further, it is to be noted that the term "hearing aid" as used herein is not limited to those devices which amplify sounds, but rather is intended to encompass all suitable devices which assist one in hearing and/or comprehending sound.
Thus, the present invention of a medical apparatus coupling device is well adapted to carry out the objects and attain the ends and advantages mentioned above as well as those inherent therein. While preferred embodiments of the invention have been described for the purpose of this disclosure, numerous changes in the construction and arrangement of parts can be made by those skilled in the art, which changes are encompassed within the spirit of this invention as defined by the appended claims.
Claims (19)
- means includes a rare-earth element..]. 3. .[.An apparatus as defined in claim 1, wherein:said first member includes electronic means for receiving an electrical signal; and.]..Iadd.A transcutaneous coupling apparatus, comprising:a first member positioned subcutaneously;a second member positioned supercutaneously; andmagnet means, cooperating with said first and second members, for magnetically securing said second member to said first member; and wherein .Iaddend.said second member includes electronic means for .[.transmitting the electrical signal.]. .Iadd.generating an electromagnetic transmission to activate electrical conduction in said first member; andsaid first member includes electronic means, responsive to said electromagnetic transmission, for electrically stimulating subcutaneous
- tissue.Iaddend.. 4. An apparatus as defined in claim 3, wherein said
- magnet means includes a rare-earth element. 5. .[.An apparatus as defined in claim 1, wherein:.]. .Iadd.A transcutaneous coupling apparatus, comprising:a first member positioned subcutaneously;a second member positioned supercutaneously; andmagnet means, cooperating with said first and second members, for magnetically securing said second member to said first member; and wherein .Iaddend.said first member includes electronic means for .[.transmitting an electrical signal.]. .Iadd.generating an electromagnetic transmission to activate electrical conduction in said second member.Iaddend.; andsaid second member includes electronic means .[.for receiving the electrical signal.]. .Iadd., responsive to said electromagnetic
- transmission, for conducting an electrical signal.Iaddend.. 6. An apparatus as defined in claim 5, wherein said magnet means includes a
- rare-earth element. 7. .[.An apparatus as defined in claim 1, wherein:.]. .Iadd.A transcutaneous coupling apparatus, comprising:a first member positioned subcutaneously;a second member positioned supercutaneously; andmagnet means for magnetically securing said second member to said first member; and wherein .Iaddend.said transcutaneous coupling apparatus is a bio-electronic signal coupling device;said first member includes:a first electrically conductive coil having two ends, each of said two ends being embedded in subcutaneous tissue; andsaid second member includes:a second electrically conductive coil; andsignal generating means, electrically connected to said second coil, for providing an electrical signal to said second coil so that said signal is electromagnetically transferred transcutaneously to said first coil for
- electrically stimulating the subcutaneous tissue. 8. An apparatus as defined in claim 7, wherein said magnet means includes a rare-earth
- element. 9. An apparatus as defined in claim 7, wherein said magnet means includes:a first rare-earth magnet associated with said first coil; anda second rare-earth magnet, associated with said second coil, for magnetically coupling with said first rare-earth magnet so that said first and second coils are positioned to achieve electromagnetically inductive
- coupling. 10. An apparatus as defined in claim 9, wherein said magnet means further includes:a third rear-earth magnet associated with said first coil; anda fourth rare-earth magnet, associated with said second coil, for magnetically coupling with said third rare-earth magnet, said third and fourth magnets having as their attractive polarities magnetic poles of opposite polarities to the attractive polarities of said first and second
- magnets, respectively. 11. A hearing .[.air.]. .Iadd.aid.Iaddend., comprising:sound detector means for detecting sound and converting it into an electrical signal;transmitter means, positioned on the ouside of the skin of a user of said hearing aid, for transmitting the electrical signal;receiver means, positioned beneath the skin of the user, for receiving the transmitted electrical signal .Iadd.and for conducting said signal into tissue beneath the skin of the user.Iaddend.; andmagnet means for coupling said transmitter means with said receiver means.Iadd., .Iaddend..[.so that.]. .Iadd.with .Iaddend.said transmitter means and said receiver means .[.are.]. on opposite sides of the surface of the skin of the user.Iadd., so that electrical conduction is activated in said receiver means and from said receiver means into tissue beneath the skin of the user in response to said transmitter means transmitting
- the electrical signal.Iaddend.. 12. A hearing aid as defined in claim 11,
- wherein said magnet means includes a rare-earth element. 13. .[.A hearing aid as defined in claim 12, wherein:.]. .Iadd.A hearing aid, comprising:sound detector means for detecting sound and converting it into an electrical signal;transmitter means, positioned on the outside of the skin of a user of said hearing aid, for transmitting the electrical signal;receiver means, positioned beneath the skin of the user, for receiving the transmitted electrical signal;magnet means for coupling said transmitter means with said receiver means so that said transmitter means and said receiver means are on opposite sides of the surface of the skin of the user; and wherein:said magnet means includes a rare-earth element; .Iaddend.said receiver means includes a first electrically conductive coil;said transmitter means includes a second electrically conductive coil, said first and second coils being electromagnetically associated by said magnet means so that said first coil is responsive to the transmitted electrical
- signal. 14. A hearing aid as defined in claim 13, wherein said first coil
- includes an end embedded in a cochlea of the user. 15. A hearing aid as defined in claim 14, wherein said sound detector means includes:transducer means for receiving a sound and converting it to a proportional electrical signal;amplifier means for amplifying the proportional electrical signal;carrier generator means for generating a carrier electrical signal; andamplitude modulation means, responsive to said amplifier means, for modulating the amplitude of the carrier electrical signal and for transferring the modulated carrier electrical signal to said second coil.
- 6. A hearing aid as defined in claim 15, wherein:said receiver means further includes a first support member having said first coil associated therewith;said transmitter means further includes a second support member having said second coil associated therewith; andsaid magnet means includes:a first rare-earth magnet associated with said first support member so that a first polarity of said first magnet is positioned closer to said transmitter means than is a second polarity thereof; anda second rare-earth magnet associated with said second support member so that a polarity thereof attractive to the first polarity of said first rare-earth magnet is positioned closer to said first magnet than is a
- non-attractive polarity thereof. 17. A hearing aid as defined in claim 11, wherein said magnet means includes a plurality of rare-earth magnets, each of said magnets being associated with a respective one of said transmitter means and said receiver means and being grouped in attractive magnetic relation with another one of said magnets associated with the other of said transmitter means and said receiver means so that said transmitter means and said receiver means are magnetically coupled in a predetermined
- alignment. 18. A hearing aid, comprising:sound detector means for detecting sound and for converting it into an electrical signal;a first electrically conductive coil having a first end embedded in the body tissue of a user of said hearing aid and having a second end embedded in a cochlea of the user;a second electrically conductive coil connected to said sound detector means and positioned outside the skin of the user;a first rare-earth magnet associated with said first coil; anda second rare-earth magnet, associated with said second coil, for magnetically coupling with said first rare-earth magnet so that said first and second coils are positioned to achieve electromagnetically inductive
- coupling. 19. A hearing aid as defined in claim 18, further comprising:a third rare-earth magnet associated with said first coil; anda fourth rare-earth magnet, associated with said second coil, for magnetically coupling with said third rare-earth magnet, said third and fourth magnets having as their attractive polarities magnetic poles of opposite polarities to the attractive polarities of said first and second
- magnets, respectively. 20. A method of .[.transcutaneously.]. coupling .[.an.]. .Iadd.a transcutaneous .Iaddend.apparatus having an implantable .Iadd.electrical .Iaddend.member and an external .Iadd.electrical .Iaddend.member, comprising the steps of:associating a first rare-earth magnet with the implantable .Iadd.electrical .Iaddend.member;associating a second rare-earth magnet with the external .Iadd.electrical .Iaddend.member;subcutaneously implanting the implantable .Iadd.electrical .Iaddend.member with the associated first rare-earth magnet; andsupercutaneously positioning the external .Iadd.electrical .Iaddend.member and associated second rare-earth magnet .[.so that.]. .Iadd.for magnetically securing .Iaddend.the second rare-earth magnet .[.is magnetically secured.]. with the first rare-earth magnet .Iadd.so that electrical conduction occurs within the implantable electrical member and electrical stimulation of subcutaneous tissue results therefrom in response to electromagnetic transmission from the external electrical
- member to the implantable electrical member.Iaddend.. 21. A method as defined in claim 20, further comprising the steps of:associating, prior to the step of subcutaneously implanting the implantable .Iadd.electrical .Iaddend.member, a third rare-earth magnet with the implantable .Iadd.electrical .Iaddend.member in opposing magnetic polarity relation with the first rare-earth magnet; andassociating a fourth rare-earth magnet with the external .Iadd.electrical .Iaddend.member in opposing magnetic polarity relation with the second rare-earth magnet so that the fourth rare-earth magnet is magnetically secured with the third rare-earth magnet during the step of supercutaneously positioning the external .Iadd.electrical .Iaddend.member and so that the external .Iadd.electrical .Iaddend.member and the implanted .Iadd.electrical .Iaddend.member are coupled in a predetermined relation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/144,011 USRE32947E (en) | 1980-09-30 | 1988-01-14 | Magnetic transcutaneous mount for external device of an associated implant |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/192,480 US4352960A (en) | 1980-09-30 | 1980-09-30 | Magnetic transcutaneous mount for external device of an associated implant |
US07/144,011 USRE32947E (en) | 1980-09-30 | 1988-01-14 | Magnetic transcutaneous mount for external device of an associated implant |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US06/192,480 Reissue US4352960A (en) | 1980-09-30 | 1980-09-30 | Magnetic transcutaneous mount for external device of an associated implant |
Publications (1)
Publication Number | Publication Date |
---|---|
USRE32947E true USRE32947E (en) | 1989-06-13 |
Family
ID=26841600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/144,011 Expired - Lifetime USRE32947E (en) | 1980-09-30 | 1988-01-14 | Magnetic transcutaneous mount for external device of an associated implant |
Country Status (1)
Country | Link |
---|---|
US (1) | USRE32947E (en) |
Cited By (134)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5314457A (en) * | 1993-04-08 | 1994-05-24 | Jeutter Dean C | Regenerative electrical |
US5314453A (en) * | 1991-12-06 | 1994-05-24 | Spinal Cord Society | Position sensitive power transfer antenna |
US5545191A (en) * | 1994-05-06 | 1996-08-13 | Alfred E. Mann Foundation For Scientific Research | Method for optimally positioning and securing the external unit of a transcutaneous transducer of the skin of a living body |
US5549658A (en) * | 1994-10-24 | 1996-08-27 | Advanced Bionics Corporation | Four-Channel cochlear system with a passive, non-hermetically sealed implant |
US5603726A (en) * | 1989-09-22 | 1997-02-18 | Alfred E. Mann Foundation For Scientific Research | Multichannel cochlear implant system including wearable speech processor |
US5876425A (en) * | 1989-09-22 | 1999-03-02 | Advanced Bionics Corporation | Power control loop for implantable tissue stimulator |
US6083149A (en) | 1997-10-22 | 2000-07-04 | Emf Therapeutics, Inc. | Magnetic field device and method for inhibiting angiogenesis and retarding growth rates of tumors in mammals |
US6103033A (en) | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
US6120676A (en) | 1997-02-06 | 2000-09-19 | Therasense, Inc. | Method of using a small volume in vitro analyte sensor |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6149577A (en) | 1999-03-18 | 2000-11-21 | Emf Therapeutics, Inc. | Apparatus and method for creating a substantially contained, finite magnetic field useful for relieving the symptoms pain and discomfort associated with degenerative diseases and disorders in mammals |
US6162611A (en) | 1993-12-02 | 2000-12-19 | E. Heller & Company | Subcutaneous glucose electrode |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6277148B1 (en) | 1999-02-11 | 2001-08-21 | Soundtec, Inc. | Middle ear magnet implant, attachment device and method, and test instrument and method |
US6348070B1 (en) | 1998-04-17 | 2002-02-19 | Med-El Elektromedizinische Gerate Ges.M.B.H | Magnetic-interference-free surgical prostheses |
US6436028B1 (en) | 1999-12-28 | 2002-08-20 | Soundtec, Inc. | Direct drive movement of body constituent |
US6632229B1 (en) * | 1999-08-19 | 2003-10-14 | Yugengaisha Pacs Optica Japan | Organ anastomosing apparatus and method |
US20040240691A1 (en) * | 2003-05-09 | 2004-12-02 | Esfandiar Grafenberg | Securing a hearing aid or an otoplastic in the ear |
US20050075700A1 (en) * | 2003-10-02 | 2005-04-07 | Medtronic, Inc. | External power source for an implantable medical device having an adjustable magnetic core and system and method related therefore |
US6907130B1 (en) * | 1998-02-13 | 2005-06-14 | University Of Iowa Research Foundation | Speech processing system and method using pseudospontaneous stimulation |
US20060244560A1 (en) * | 2002-04-01 | 2006-11-02 | Med-El Elektromedizinische Geraete Gmbh | Reducing effect of magnetic and electromagnetic fields on an implant's magnet and/or electronics |
US7266209B1 (en) | 2000-01-05 | 2007-09-04 | David William House | Cochlear implants with a stimulus in the human ultrasonic range and method for stimulating a cochlea |
US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US20080281171A1 (en) * | 2007-05-08 | 2008-11-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and methods |
US20090134721A1 (en) * | 2002-04-01 | 2009-05-28 | Med-El Elektromedisinische Geraete Gmbh | MRI-safe Electro-magnetic Tranducer |
US7609061B2 (en) | 2007-07-13 | 2009-10-27 | Med-El Elektromedizinische Geraete Gmbh | Demagnetized implant for magnetic resonance imaging |
US7642887B2 (en) | 2002-04-01 | 2010-01-05 | Med-El Elektromedizinische Geraete Gmbh | System and method for reducing effect of magnetic fields on a magnetic transducer |
US7651460B2 (en) | 2004-03-22 | 2010-01-26 | The Board Of Regents Of The University Of Oklahoma | Totally implantable hearing system |
US20100046778A1 (en) * | 2003-05-08 | 2010-02-25 | Crawford Scott A | Integrated cochlear implant headpiece |
US20100046779A1 (en) * | 2003-05-08 | 2010-02-25 | Crawford Scott A | Modular speech processor headpiece |
US20100076287A1 (en) * | 1998-10-08 | 2010-03-25 | Feldman Benjamin J | Small Volume In Vitro Analyte Sensor and Methods of Making |
US20100076524A1 (en) * | 2003-10-02 | 2010-03-25 | Medtronic, Inc. | Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
WO2010122142A1 (en) * | 2009-04-23 | 2010-10-28 | Centre Hospitalier Universitaire De Rouen | Subcutaneous device for electrical percutaneous connection |
US20110022120A1 (en) * | 2009-07-22 | 2011-01-27 | Vibrant Med-El Hearing Technology Gmbh | Magnetic Attachment Arrangement for Implantable Device |
US7920907B2 (en) | 2006-06-07 | 2011-04-05 | Abbott Diabetes Care Inc. | Analyte monitoring system and method |
US7976778B2 (en) | 2001-04-02 | 2011-07-12 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US8107661B1 (en) | 2003-05-08 | 2012-01-31 | Advanced Bionics, Llc | Listening device cap |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US8149117B2 (en) | 2007-05-08 | 2012-04-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8287454B2 (en) | 1998-04-30 | 2012-10-16 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8362904B2 (en) | 2007-05-08 | 2013-01-29 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8414750B2 (en) | 1991-03-04 | 2013-04-09 | Abbott Diabetes Care Inc. | Subcutaneous glucose electrode |
US8437966B2 (en) | 2003-04-04 | 2013-05-07 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8512239B2 (en) | 2003-06-10 | 2013-08-20 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US8545261B2 (en) | 2009-04-23 | 2013-10-01 | Centre Hospitalier Universitaire De Rouen | Electrical connection system between an electrical implanted medical device |
US8545403B2 (en) | 2005-12-28 | 2013-10-01 | Abbott Diabetes Care Inc. | Medical device insertion |
US8571624B2 (en) | 2004-12-29 | 2013-10-29 | Abbott Diabetes Care Inc. | Method and apparatus for mounting a data transmission device in a communication system |
US8602991B2 (en) | 2005-08-30 | 2013-12-10 | Abbott Diabetes Care Inc. | Analyte sensor introducer and methods of use |
US8612159B2 (en) | 1998-04-30 | 2013-12-17 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8613703B2 (en) | 2007-05-31 | 2013-12-24 | Abbott Diabetes Care Inc. | Insertion devices and methods |
US8639353B2 (en) | 2009-04-23 | 2014-01-28 | Centre Hospitalier Universitaire De Rouen | Electrical connection device implantable in the human body |
US8652043B2 (en) | 2001-01-02 | 2014-02-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8764621B2 (en) | 2011-07-11 | 2014-07-01 | Vascor, Inc. | Transcutaneous power transmission and communication for implanted heart assist and other devices |
US8764657B2 (en) | 2010-03-24 | 2014-07-01 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US8774930B2 (en) | 2009-07-22 | 2014-07-08 | Vibrant Med-El Hearing Technology Gmbh | Electromagnetic bone conduction hearing device |
US8771183B2 (en) | 2004-02-17 | 2014-07-08 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8852101B2 (en) | 2005-12-28 | 2014-10-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US8897475B2 (en) | 2011-12-22 | 2014-11-25 | Vibrant Med-El Hearing Technology Gmbh | Magnet arrangement for bone conduction hearing implant |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US9022917B2 (en) | 2012-07-16 | 2015-05-05 | Sophono, Inc. | Magnetic spacer systems, devices, components and methods for bone conduction hearing aids |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9119010B2 (en) | 2011-12-09 | 2015-08-25 | Sophono, Inc. | Implantable sound transmission device for magnetic hearing aid, and corresponding systems, devices and components |
US9179228B2 (en) | 2011-12-09 | 2015-11-03 | Sophono, Inc. | Systems devices, components and methods for providing acoustic isolation between microphones and transducers in bone conduction magnetic hearing aids |
US9210521B2 (en) | 2012-07-16 | 2015-12-08 | Sophono, Inc. | Abutment attachment systems, mechanisms, devices, components and methods for bone conduction hearing aids |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
US9258656B2 (en) | 2011-12-09 | 2016-02-09 | Sophono, Inc. | Sound acquisition and analysis systems, devices and components for magnetic hearing aids |
US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US9295425B2 (en) | 2002-04-01 | 2016-03-29 | Med-El Elektromedizinische Geraete Gmbh | Transducer for stapedius monitoring |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US9320461B2 (en) | 2009-09-29 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
US9351669B2 (en) | 2009-09-30 | 2016-05-31 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
US9402570B2 (en) | 2011-12-11 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US9420388B2 (en) | 2012-07-09 | 2016-08-16 | Med-El Elektromedizinische Geraete Gmbh | Electromagnetic bone conduction hearing device |
US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
US9526810B2 (en) | 2011-12-09 | 2016-12-27 | Sophono, Inc. | Systems, devices, components and methods for improved acoustic coupling between a bone conduction hearing device and a patient's head or skull |
US9572534B2 (en) | 2010-06-29 | 2017-02-21 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US9736601B2 (en) | 2012-07-16 | 2017-08-15 | Sophono, Inc. | Adjustable magnetic systems, devices, components and methods for bone conduction hearing aids |
US9743862B2 (en) | 2011-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Systems and methods for transcutaneously implanting medical devices |
US9788125B2 (en) | 2012-07-16 | 2017-10-10 | Sophono, Inc. | Systems, devices, components and methods for providing acoustic isolation between microphones and transducers in bone conduction magnetic hearing aids |
US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
US9919154B2 (en) | 2015-12-18 | 2018-03-20 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US9980669B2 (en) | 2011-11-07 | 2018-05-29 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US10028680B2 (en) | 2006-04-28 | 2018-07-24 | Abbott Diabetes Care Inc. | Introducer assembly and methods of use |
US10058702B2 (en) | 2003-04-09 | 2018-08-28 | Cochlear Limited | Implant magnet system |
US10130807B2 (en) | 2015-06-12 | 2018-11-20 | Cochlear Limited | Magnet management MRI compatibility |
US10194863B2 (en) | 2005-09-30 | 2019-02-05 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
US10300276B2 (en) | 2015-05-28 | 2019-05-28 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US10532209B2 (en) | 2015-12-18 | 2020-01-14 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US10576276B2 (en) | 2016-04-29 | 2020-03-03 | Cochlear Limited | Implanted magnet management in the face of external magnetic fields |
CN110944715A (en) * | 2017-08-02 | 2020-03-31 | Med-El电气医疗器械有限公司 | MRI safe and force optimized implantable ring magnet system with enhanced inductive link |
US10646718B2 (en) | 2016-11-15 | 2020-05-12 | Advanced Bionics Ag | Cochlear implants and magnets for use with same |
US10646712B2 (en) | 2017-09-13 | 2020-05-12 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus |
US10674944B2 (en) | 2015-05-14 | 2020-06-09 | Abbott Diabetes Care Inc. | Compact medical device inserters and related systems and methods |
US10806936B2 (en) | 2015-11-20 | 2020-10-20 | Advanced Bionics Ag | Cochlear implants and magnets for use with same |
USD902408S1 (en) | 2003-11-05 | 2020-11-17 | Abbott Diabetes Care Inc. | Analyte sensor control unit |
US10848882B2 (en) | 2007-05-24 | 2020-11-24 | Cochlear Limited | Implant abutment |
US10874338B2 (en) | 2010-06-29 | 2020-12-29 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US10917730B2 (en) | 2015-09-14 | 2021-02-09 | Cochlear Limited | Retention magnet system for medical device |
USD924406S1 (en) | 2010-02-01 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
US11071478B2 (en) | 2017-01-23 | 2021-07-27 | Abbott Diabetes Care Inc. | Systems, devices and methods for analyte sensor insertion |
US11097095B2 (en) | 2017-04-11 | 2021-08-24 | Advanced Bionics Ag | Cochlear implants, magnets for use with same and magnet retrofit methods |
US11287495B2 (en) | 2017-05-22 | 2022-03-29 | Advanced Bionics Ag | Methods and apparatus for use with cochlear implants having magnet apparatus with magnetic material particles |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US11364384B2 (en) | 2017-04-25 | 2022-06-21 | Advanced Bionics Ag | Cochlear implants having impact resistant MRI-compatible magnet apparatus |
USD961778S1 (en) | 2006-02-28 | 2022-08-23 | Abbott Diabetes Care Inc. | Analyte sensor device |
USD962446S1 (en) | 2009-08-31 | 2022-08-30 | Abbott Diabetes Care, Inc. | Analyte sensor device |
US11471679B2 (en) | 2017-10-26 | 2022-10-18 | Advanced Bionics Ag | Headpieces and implantable cochlear stimulation systems including the same |
US11595768B2 (en) | 2016-12-02 | 2023-02-28 | Cochlear Limited | Retention force increasing components |
USD982762S1 (en) | 2020-12-21 | 2023-04-04 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
US11638823B2 (en) | 2018-02-15 | 2023-05-02 | Advanced Bionics Ag | Headpieces and implantable cochlear stimulation systems including the same |
US11792587B1 (en) | 2015-06-26 | 2023-10-17 | Cochlear Limited | Magnetic retention device |
USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11918808B2 (en) | 2022-12-01 | 2024-03-05 | Cochlear Limited | Magnet management MRI compatibility |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2402392A (en) * | 1941-10-28 | 1946-06-18 | Radio Patents Corp | Electromagnetic sound-transmission apparatus |
US3061689A (en) * | 1957-05-27 | 1962-10-30 | Beltone Hearing Aid Company | Hearing aid |
US3346704A (en) * | 1963-12-27 | 1967-10-10 | Jack L Mahoney | Means for aiding hearing |
US3557775A (en) * | 1963-12-27 | 1971-01-26 | Jack Lawrence Mahoney | Method of implanting a hearing aid |
US3565073A (en) * | 1968-04-15 | 1971-02-23 | Jerry D Giesy | Method and means for attaching a body appendage |
US3712962A (en) * | 1971-04-05 | 1973-01-23 | J Epley | Implantable piezoelectric hearing aid |
US3764748A (en) * | 1972-05-19 | 1973-10-09 | J Branch | Implanted hearing aids |
US3870832A (en) * | 1972-07-18 | 1975-03-11 | John M Fredrickson | Implantable electromagnetic hearing aid |
US4279256A (en) * | 1974-10-09 | 1981-07-21 | Louis Bucalo | Nerve stimulation method |
-
1988
- 1988-01-14 US US07/144,011 patent/USRE32947E/en not_active Expired - Lifetime
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2402392A (en) * | 1941-10-28 | 1946-06-18 | Radio Patents Corp | Electromagnetic sound-transmission apparatus |
US3061689A (en) * | 1957-05-27 | 1962-10-30 | Beltone Hearing Aid Company | Hearing aid |
US3346704A (en) * | 1963-12-27 | 1967-10-10 | Jack L Mahoney | Means for aiding hearing |
US3557775A (en) * | 1963-12-27 | 1971-01-26 | Jack Lawrence Mahoney | Method of implanting a hearing aid |
US3565073A (en) * | 1968-04-15 | 1971-02-23 | Jerry D Giesy | Method and means for attaching a body appendage |
US3712962A (en) * | 1971-04-05 | 1973-01-23 | J Epley | Implantable piezoelectric hearing aid |
US3764748A (en) * | 1972-05-19 | 1973-10-09 | J Branch | Implanted hearing aids |
US3870832A (en) * | 1972-07-18 | 1975-03-11 | John M Fredrickson | Implantable electromagnetic hearing aid |
US4279256A (en) * | 1974-10-09 | 1981-07-21 | Louis Bucalo | Nerve stimulation method |
Non-Patent Citations (18)
Title |
---|
"Cochlear Implant Utilizing Rare Earth Magnets", Dormer et al, Am. Jrnl. Otology, vol. 2, #1, 7/1980. |
"Cochlear Implants," by William F. House, M.D., printed in The Annals of Otology, Rhinology & Laryngology, May-Jun., 1976. |
"Magnetic and Physical Properties of Commercially Available Rare Earth-Cobalt Permanent Magnets," by H. F. Mildrum et al., 1974. |
"Magnetic Continent Colostomy Device," by J. Alexander-Williams et al., printed in British Medical Journal, May, 1977. |
"Magnetic Materials as Biological Implants--Criteria for Selection," by Jack Driller et al., 1973. |
"Neural Prostheses," by F. Terry Hambrecht, printed in Ann. Rev. Biophys. Bioeng., 1979. |
"Nonsuture Microvascular Anastomosis Using Magnet Rings: Preliminary Report," by Yoshiro Obora, M.D. et al., Surg. Neurol., vol. 9, Feb. 1978. |
"Preliminary Experience with Lid Magnets for Paralytic Lagophthalmos," by E. N. Hinzpeter et al. |
"Rare Earth-Cobalt Magnets in Modern Medicine," by G. Hennig, H. Feustel and K. Hennig, 1975. |
Cochlear Implant Utilizing Rare Earth Magnets , Dormer et al, Am. Jrnl. Otology, vol. 2, 1, 7/1980. * |
Cochlear Implants, by William F. House, M.D., printed in The Annals of Otology, Rhinology & Laryngology, May Jun., 1976. * |
Magnetic and Physical Properties of Commercially Available Rare Earth Cobalt Permanent Magnets, by H. F. Mildrum et al., 1974. * |
Magnetic Continent Colostomy Device, by J. Alexander Williams et al., printed in British Medical Journal, May, 1977. * |
Magnetic Materials as Biological Implants Criteria for Selection, by Jack Driller et al., 1973. * |
Neural Prostheses, by F. Terry Hambrecht, printed in Ann. Rev. Biophys. Bioeng., 1979. * |
Nonsuture Microvascular Anastomosis Using Magnet Rings: Preliminary Report, by Yoshiro Obora, M.D. et al., Surg. Neurol., vol. 9, Feb. 1978. * |
Preliminary Experience with Lid Magnets for Paralytic Lagophthalmos, by E. N. Hinzpeter et al. * |
Rare Earth Cobalt Magnets in Modern Medicine, by G. Hennig, H. Feustel and K. Hennig, 1975. * |
Cited By (440)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5603726A (en) * | 1989-09-22 | 1997-02-18 | Alfred E. Mann Foundation For Scientific Research | Multichannel cochlear implant system including wearable speech processor |
US5876425A (en) * | 1989-09-22 | 1999-03-02 | Advanced Bionics Corporation | Power control loop for implantable tissue stimulator |
US5609616A (en) * | 1989-09-22 | 1997-03-11 | Alfred E. Mann Foundation For Scientific Research | Physician's testing system and method for testing implantable cochlear stimulator |
US8741590B2 (en) | 1991-03-04 | 2014-06-03 | Abbott Diabetes Care Inc. | Subcutaneous glucose electrode |
US6514718B2 (en) | 1991-03-04 | 2003-02-04 | Therasense, Inc. | Subcutaneous glucose electrode |
US8588881B2 (en) | 1991-03-04 | 2013-11-19 | Abbott Diabetes Care Inc. | Subcutaneous glucose electrode |
US8414750B2 (en) | 1991-03-04 | 2013-04-09 | Abbott Diabetes Care Inc. | Subcutaneous glucose electrode |
US8414749B2 (en) | 1991-03-04 | 2013-04-09 | Abbott Diabetes Care Inc. | Subcutaneous glucose electrode |
US6881551B2 (en) | 1991-03-04 | 2005-04-19 | Therasense, Inc. | Subcutaneous glucose electrode |
US5314453A (en) * | 1991-12-06 | 1994-05-24 | Spinal Cord Society | Position sensitive power transfer antenna |
US5314457A (en) * | 1993-04-08 | 1994-05-24 | Jeutter Dean C | Regenerative electrical |
US6284478B1 (en) | 1993-12-02 | 2001-09-04 | E. Heller & Company | Subcutaneous glucose electrode |
US6162611A (en) | 1993-12-02 | 2000-12-19 | E. Heller & Company | Subcutaneous glucose electrode |
US6329161B1 (en) | 1993-12-02 | 2001-12-11 | Therasense, Inc. | Subcutaneous glucose electrode |
US5545191A (en) * | 1994-05-06 | 1996-08-13 | Alfred E. Mann Foundation For Scientific Research | Method for optimally positioning and securing the external unit of a transcutaneous transducer of the skin of a living body |
US5749912A (en) * | 1994-10-24 | 1998-05-12 | House Ear Institute | Low-cost, four-channel cochlear implant |
US5549658A (en) * | 1994-10-24 | 1996-08-27 | Advanced Bionics Corporation | Four-Channel cochlear system with a passive, non-hermetically sealed implant |
US8118992B2 (en) | 1997-02-06 | 2012-02-21 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US7988845B2 (en) | 1997-02-06 | 2011-08-02 | Abbott Diabetes Care Inc. | Integrated lancing and measurement device and analyte measuring methods |
US8114270B2 (en) | 1997-02-06 | 2012-02-14 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8114271B2 (en) | 1997-02-06 | 2012-02-14 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8105476B2 (en) | 1997-02-06 | 2012-01-31 | Abbott Diabetes Care Inc. | Integrated lancing and measurement device |
US8142643B2 (en) | 1997-02-06 | 2012-03-27 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US6551494B1 (en) | 1997-02-06 | 2003-04-22 | Therasense, Inc. | Small volume in vitro analyte sensor |
US6143164A (en) | 1997-02-06 | 2000-11-07 | E. Heller & Company | Small volume in vitro analyte sensor |
US6576101B1 (en) | 1997-02-06 | 2003-06-10 | Therasense, Inc. | Small volume in vitro analyte sensor |
US8123929B2 (en) | 1997-02-06 | 2012-02-28 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8142642B2 (en) | 1997-02-06 | 2012-03-27 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US7909984B2 (en) | 1997-02-06 | 2011-03-22 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US6120676A (en) | 1997-02-06 | 2000-09-19 | Therasense, Inc. | Method of using a small volume in vitro analyte sensor |
US9234864B2 (en) | 1997-02-06 | 2016-01-12 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US7906009B2 (en) | 1997-02-06 | 2011-03-15 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US6083149A (en) | 1997-10-22 | 2000-07-04 | Emf Therapeutics, Inc. | Magnetic field device and method for inhibiting angiogenesis and retarding growth rates of tumors in mammals |
US6907130B1 (en) * | 1998-02-13 | 2005-06-14 | University Of Iowa Research Foundation | Speech processing system and method using pseudospontaneous stimulation |
US8706180B2 (en) | 1998-03-04 | 2014-04-22 | Abbott Diabetes Care Inc. | Electrochemical analyte sensor |
US6973706B2 (en) | 1998-03-04 | 2005-12-13 | Therasense, Inc. | Method of making a transcutaneous electrochemical sensor |
US8168051B2 (en) | 1998-03-04 | 2012-05-01 | Abbott Diabetes Care Inc. | Sensor for determination of glucose |
US6103033A (en) | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
US8273227B2 (en) | 1998-03-04 | 2012-09-25 | Abbott Diabetes Care Inc. | Sensor for in vitro determination of glucose |
US20080287760A1 (en) * | 1998-03-04 | 2008-11-20 | Therasense, Inc. | method of making an electrochemical sensor |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US8136220B2 (en) | 1998-03-04 | 2012-03-20 | Abbott Diabetes Care Inc. | Method of making an electrochemical sensor |
US8117734B2 (en) | 1998-03-04 | 2012-02-21 | Abbott Diabetes Care Inc. | Method of making an electrochemical sensor |
US7003340B2 (en) | 1998-03-04 | 2006-02-21 | Abbott Diabetes Care Inc. | Electrochemical analyte sensor |
US6484046B1 (en) | 1998-03-04 | 2002-11-19 | Therasense, Inc. | Electrochemical analyte sensor |
US7996054B2 (en) | 1998-03-04 | 2011-08-09 | Abbott Diabetes Care Inc. | Electrochemical analyte sensor |
US20060042080A1 (en) * | 1998-03-04 | 2006-03-02 | Therasense, Inc. | Method of making an electrochemical sensor |
US7721412B2 (en) | 1998-03-04 | 2010-05-25 | Abbott Diabetes Care Inc. | Method of making an electrochemical sensor |
US7879213B2 (en) | 1998-03-04 | 2011-02-01 | Abbott Diabetes Care Inc. | Sensor for in vitro determination of glucose |
US7861397B2 (en) | 1998-03-04 | 2011-01-04 | Abbott Diabetes Care Inc. | Method of making an electrochemical sensor |
US6348070B1 (en) | 1998-04-17 | 2002-02-19 | Med-El Elektromedizinische Gerate Ges.M.B.H | Magnetic-interference-free surgical prostheses |
US8380273B2 (en) | 1998-04-30 | 2013-02-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8670815B2 (en) | 1998-04-30 | 2014-03-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8880137B2 (en) | 1998-04-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9014773B2 (en) | 1998-04-30 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US7860544B2 (en) | 1998-04-30 | 2010-12-28 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8840553B2 (en) | 1998-04-30 | 2014-09-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US7869853B1 (en) | 1998-04-30 | 2011-01-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8473021B2 (en) | 1998-04-30 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9011331B2 (en) | 1998-04-30 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10478108B2 (en) | 1998-04-30 | 2019-11-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US7885699B2 (en) | 1998-04-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8774887B2 (en) | 1998-04-30 | 2014-07-08 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8660627B2 (en) | 1998-04-30 | 2014-02-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9042953B2 (en) | 1998-04-30 | 2015-05-26 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8226558B2 (en) | 1998-04-30 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8666469B2 (en) | 1998-04-30 | 2014-03-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8649841B2 (en) | 1998-04-30 | 2014-02-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6565509B1 (en) | 1998-04-30 | 2003-05-20 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8409131B2 (en) | 1998-04-30 | 2013-04-02 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8391945B2 (en) | 1998-04-30 | 2013-03-05 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8641619B2 (en) | 1998-04-30 | 2014-02-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8372005B2 (en) | 1998-04-30 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8366614B2 (en) | 1998-04-30 | 2013-02-05 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066697B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8357091B2 (en) | 1998-04-30 | 2013-01-22 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8353829B2 (en) | 1998-04-30 | 2013-01-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346336B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8744545B2 (en) | 1998-04-30 | 2014-06-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9326714B2 (en) | 1998-04-30 | 2016-05-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8734348B2 (en) | 1998-04-30 | 2014-05-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8597189B2 (en) | 1998-04-30 | 2013-12-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8738109B2 (en) | 1998-04-30 | 2014-05-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8672844B2 (en) | 1998-04-30 | 2014-03-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8612159B2 (en) | 1998-04-30 | 2013-12-17 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8306598B2 (en) | 1998-04-30 | 2012-11-06 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8287454B2 (en) | 1998-04-30 | 2012-10-16 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8162829B2 (en) | 1998-04-30 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8734346B2 (en) | 1998-04-30 | 2014-05-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8273022B2 (en) | 1998-04-30 | 2012-09-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8617071B2 (en) | 1998-04-30 | 2013-12-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8622906B2 (en) | 1998-04-30 | 2014-01-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8275439B2 (en) | 1998-04-30 | 2012-09-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8175673B2 (en) | 1998-04-30 | 2012-05-08 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8177716B2 (en) | 1998-04-30 | 2012-05-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066694B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8265726B2 (en) | 1998-04-30 | 2012-09-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8260392B2 (en) | 1998-04-30 | 2012-09-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8255031B2 (en) | 1998-04-30 | 2012-08-28 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8235896B2 (en) | 1998-04-30 | 2012-08-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8231532B2 (en) | 1998-04-30 | 2012-07-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9072477B2 (en) | 1998-04-30 | 2015-07-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8224413B2 (en) | 1998-04-30 | 2012-07-17 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8226555B2 (en) | 1998-04-30 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8226557B2 (en) | 1998-04-30 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US20100076287A1 (en) * | 1998-10-08 | 2010-03-25 | Feldman Benjamin J | Small Volume In Vitro Analyte Sensor and Methods of Making |
US8449758B2 (en) | 1998-10-08 | 2013-05-28 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8221685B2 (en) | 1998-10-08 | 2012-07-17 | Abbott Diabetes Care Inc. | Small volume in vitro sensor and methods of making |
US8211363B2 (en) | 1998-10-08 | 2012-07-03 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8192611B2 (en) | 1998-10-08 | 2012-06-05 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8650751B2 (en) | 1998-10-08 | 2014-02-18 | Abbott Diabetes Care Inc. | Methods of making small volume in vitro analyte sensors |
US8701282B2 (en) | 1998-10-08 | 2014-04-22 | Abbott Diabetes Care Inc. | Method for manufacturing a biosensor |
US8186044B2 (en) | 1998-10-08 | 2012-05-29 | Abbott Diabetes Care Inc. | Method of manufacturing small volume in vitro analyte sensors |
US8187895B2 (en) | 1998-10-08 | 2012-05-29 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8182671B2 (en) | 1998-10-08 | 2012-05-22 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8262996B2 (en) | 1998-10-08 | 2012-09-11 | Abbott Diabetes Care Inc. | Small volume in vitro sensor and methods of making |
US8268163B2 (en) | 1998-10-08 | 2012-09-18 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8728297B2 (en) | 1998-10-08 | 2014-05-20 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8182670B2 (en) | 1998-10-08 | 2012-05-22 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8268144B2 (en) | 1998-10-08 | 2012-09-18 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US9234863B2 (en) | 1998-10-08 | 2016-01-12 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9291592B2 (en) | 1998-10-08 | 2016-03-22 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8272125B2 (en) | 1998-10-08 | 2012-09-25 | Abbott Diabetes Care Inc. | Method of manufacturing in vitro analyte sensors |
US8163164B2 (en) | 1998-10-08 | 2012-04-24 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8273241B2 (en) | 1998-10-08 | 2012-09-25 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8153063B2 (en) | 1998-10-08 | 2012-04-10 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US9891185B2 (en) | 1998-10-08 | 2018-02-13 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9316609B2 (en) | 1998-10-08 | 2016-04-19 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8118993B2 (en) | 1998-10-08 | 2012-02-21 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US9341591B2 (en) | 1998-10-08 | 2016-05-17 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8226815B2 (en) | 1998-10-08 | 2012-07-24 | Abbott Diabetes Care Inc. | Small volume in vitro sensor and methods of making |
US8091220B2 (en) | 1998-10-08 | 2012-01-10 | Abbott Diabetes Care Inc. | Methods of making small volume in vitro analyte sensors |
US8087162B2 (en) | 1998-10-08 | 2012-01-03 | Abbott Diabetes Care Inc. | Methods of making small volume in vitro analyte sensors |
US8083928B2 (en) | 1998-10-08 | 2011-12-27 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8083929B2 (en) | 1998-10-08 | 2011-12-27 | Abbott Diabetes Care Inc. | Small volume in vitro sensor and methods of making |
US8372261B2 (en) | 1998-10-08 | 2013-02-12 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8083924B2 (en) | 1998-10-08 | 2011-12-27 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8377378B2 (en) | 1998-10-08 | 2013-02-19 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8425758B2 (en) | 1998-10-08 | 2013-04-23 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8425743B2 (en) | 1998-10-08 | 2013-04-23 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US6277148B1 (en) | 1999-02-11 | 2001-08-21 | Soundtec, Inc. | Middle ear magnet implant, attachment device and method, and test instrument and method |
US6149577A (en) | 1999-03-18 | 2000-11-21 | Emf Therapeutics, Inc. | Apparatus and method for creating a substantially contained, finite magnetic field useful for relieving the symptoms pain and discomfort associated with degenerative diseases and disorders in mammals |
US6632229B1 (en) * | 1999-08-19 | 2003-10-14 | Yugengaisha Pacs Optica Japan | Organ anastomosing apparatus and method |
US6436028B1 (en) | 1999-12-28 | 2002-08-20 | Soundtec, Inc. | Direct drive movement of body constituent |
US7266209B1 (en) | 2000-01-05 | 2007-09-04 | David William House | Cochlear implants with a stimulus in the human ultrasonic range and method for stimulating a cochlea |
US8668645B2 (en) | 2001-01-02 | 2014-03-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9011332B2 (en) | 2001-01-02 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9610034B2 (en) | 2001-01-02 | 2017-04-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8652043B2 (en) | 2001-01-02 | 2014-02-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9498159B2 (en) | 2001-01-02 | 2016-11-22 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US7976778B2 (en) | 2001-04-02 | 2011-07-12 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus |
US9477811B2 (en) | 2001-04-02 | 2016-10-25 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus and methods |
US8236242B2 (en) | 2001-04-02 | 2012-08-07 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus and methods |
US8765059B2 (en) | 2001-04-02 | 2014-07-01 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus |
US8268243B2 (en) | 2001-04-02 | 2012-09-18 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus and methods |
US20100004716A1 (en) * | 2002-04-01 | 2010-01-07 | Med-El Elektromedizinische Geraete Gmbh | Reducing Effect of Magnetic and Electromagnetic Fields on an Implant's Magnet and/or Electronics |
USRE48647E1 (en) | 2002-04-01 | 2021-07-13 | Med-El Elektromedizinische Geraete Gmbh | Reducing effect of magnetic and electromagnetic fields on an implant's magnet and/or electronics |
US7976453B2 (en) | 2002-04-01 | 2011-07-12 | Med-El Elektromedizinische Geraete Gmbh | Reducing effect of magnetic and electromagnetic fields on an implant's magnet and/or electronics |
US8013699B2 (en) | 2002-04-01 | 2011-09-06 | Med-El Elektromedizinische Geraete Gmbh | MRI-safe electro-magnetic tranducer |
US20060244560A1 (en) * | 2002-04-01 | 2006-11-02 | Med-El Elektromedizinische Geraete Gmbh | Reducing effect of magnetic and electromagnetic fields on an implant's magnet and/or electronics |
US9295425B2 (en) | 2002-04-01 | 2016-03-29 | Med-El Elektromedizinische Geraete Gmbh | Transducer for stapedius monitoring |
US20090134721A1 (en) * | 2002-04-01 | 2009-05-28 | Med-El Elektromedisinische Geraete Gmbh | MRI-safe Electro-magnetic Tranducer |
US7566296B2 (en) | 2002-04-01 | 2009-07-28 | Med-El Elektromedizinische Geraete Gmbh | Reducing effect of magnetic and electromagnetic fields on an implant's magnet and/or electronics |
US7642887B2 (en) | 2002-04-01 | 2010-01-05 | Med-El Elektromedizinische Geraete Gmbh | System and method for reducing effect of magnetic fields on a magnetic transducer |
US11141084B2 (en) | 2002-11-05 | 2021-10-12 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US7582059B2 (en) | 2002-11-05 | 2009-09-01 | Abbott Diabetes Care Inc. | Sensor inserter methods of use |
US11116430B2 (en) | 2002-11-05 | 2021-09-14 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US10973443B2 (en) | 2002-11-05 | 2021-04-13 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US8029442B2 (en) | 2002-11-05 | 2011-10-04 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US9980670B2 (en) | 2002-11-05 | 2018-05-29 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US8622903B2 (en) | 2002-12-31 | 2014-01-07 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US9962091B2 (en) | 2002-12-31 | 2018-05-08 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US10750952B2 (en) | 2002-12-31 | 2020-08-25 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US10039881B2 (en) | 2002-12-31 | 2018-08-07 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US8187183B2 (en) | 2002-12-31 | 2012-05-29 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US8437966B2 (en) | 2003-04-04 | 2013-05-07 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
US8483974B2 (en) | 2003-04-04 | 2013-07-09 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
US8560250B2 (en) | 2003-04-04 | 2013-10-15 | Abbott Laboratories | Method and system for transferring analyte test data |
US8682598B2 (en) | 2003-04-04 | 2014-03-25 | Abbott Laboratories | Method and system for transferring analyte test data |
US11135440B2 (en) | 2003-04-09 | 2021-10-05 | Cochlear Limited | Implant magnet system |
US10058702B2 (en) | 2003-04-09 | 2018-08-28 | Cochlear Limited | Implant magnet system |
US11090498B2 (en) | 2003-04-09 | 2021-08-17 | Cochlear Limited | Implant magnet system |
US10232171B2 (en) | 2003-04-09 | 2019-03-19 | Cochlear Limited | Implant magnet system |
US8983102B2 (en) | 2003-05-08 | 2015-03-17 | Advanced Bionics Ag | Speech processor headpiece |
US10462588B2 (en) | 2003-05-08 | 2019-10-29 | Advanced Bionics Ag | Speech processor headpiece |
US20100046778A1 (en) * | 2003-05-08 | 2010-02-25 | Crawford Scott A | Integrated cochlear implant headpiece |
US10200798B2 (en) | 2003-05-08 | 2019-02-05 | Advanced Bionics Ag | Cochlear implant headpiece |
US8270647B2 (en) | 2003-05-08 | 2012-09-18 | Advanced Bionics, Llc | Modular speech processor headpiece |
US20100046779A1 (en) * | 2003-05-08 | 2010-02-25 | Crawford Scott A | Modular speech processor headpiece |
US8170253B1 (en) | 2003-05-08 | 2012-05-01 | Advanced Bionics | Listening device cap |
US8811643B2 (en) | 2003-05-08 | 2014-08-19 | Advanced Bionics | Integrated cochlear implant headpiece |
US10960208B2 (en) | 2003-05-08 | 2021-03-30 | Advanced Bionics Ag | Cochlear implant headpiece |
US11583677B2 (en) | 2003-05-08 | 2023-02-21 | Advanced Bionics Ag | Cochlear implant headpiece |
US8107661B1 (en) | 2003-05-08 | 2012-01-31 | Advanced Bionics, Llc | Listening device cap |
US11318308B2 (en) | 2003-05-08 | 2022-05-03 | Advanced Bionics Ag | Speech processor headpiece |
US20040240691A1 (en) * | 2003-05-09 | 2004-12-02 | Esfandiar Grafenberg | Securing a hearing aid or an otoplastic in the ear |
US8512239B2 (en) | 2003-06-10 | 2013-08-20 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US9730584B2 (en) | 2003-06-10 | 2017-08-15 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US8647269B2 (en) | 2003-06-10 | 2014-02-11 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US11318250B2 (en) | 2003-10-02 | 2022-05-03 | Medtronic, Inc. | Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device |
US20100076524A1 (en) * | 2003-10-02 | 2010-03-25 | Medtronic, Inc. | Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device |
US8165678B2 (en) * | 2003-10-02 | 2012-04-24 | Medtronic, Inc. | Inductively rechargeable external energy source, charger and system for a transcutaneous inductive charger for an implantable medical device |
US20110022125A1 (en) * | 2003-10-02 | 2011-01-27 | Medtronic, Inc. | Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device |
US10369275B2 (en) | 2003-10-02 | 2019-08-06 | Medtronic, Inc. | Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device |
US7286881B2 (en) * | 2003-10-02 | 2007-10-23 | Medtronic, Inc. | External power source having an adjustable magnetic core and method of use |
US9463324B2 (en) | 2003-10-02 | 2016-10-11 | Medtronic, Inc. | Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device |
US9821112B2 (en) | 2003-10-02 | 2017-11-21 | Medtronic, Inc. | Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device |
US8554322B2 (en) | 2003-10-02 | 2013-10-08 | Medtronic, Inc. | Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device |
US20050075700A1 (en) * | 2003-10-02 | 2005-04-07 | Medtronic, Inc. | External power source for an implantable medical device having an adjustable magnetic core and system and method related therefore |
US8005547B2 (en) * | 2003-10-02 | 2011-08-23 | Medtronic, Inc. | Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device |
USD902408S1 (en) | 2003-11-05 | 2020-11-17 | Abbott Diabetes Care Inc. | Analyte sensor control unit |
USD914881S1 (en) | 2003-11-05 | 2021-03-30 | Abbott Diabetes Care Inc. | Analyte sensor electronic mount |
US8771183B2 (en) | 2004-02-17 | 2014-07-08 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US7651460B2 (en) | 2004-03-22 | 2010-01-26 | The Board Of Regents Of The University Of Oklahoma | Totally implantable hearing system |
US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
US8571624B2 (en) | 2004-12-29 | 2013-10-29 | Abbott Diabetes Care Inc. | Method and apparatus for mounting a data transmission device in a communication system |
US11160475B2 (en) | 2004-12-29 | 2021-11-02 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US8602991B2 (en) | 2005-08-30 | 2013-12-10 | Abbott Diabetes Care Inc. | Analyte sensor introducer and methods of use |
US9480421B2 (en) | 2005-09-30 | 2016-11-01 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
USD979766S1 (en) | 2005-09-30 | 2023-02-28 | Abbott Diabetes Care Inc. | Analyte sensor device |
US10342489B2 (en) | 2005-09-30 | 2019-07-09 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US11457869B2 (en) | 2005-09-30 | 2022-10-04 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
US9775563B2 (en) | 2005-09-30 | 2017-10-03 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
US10194863B2 (en) | 2005-09-30 | 2019-02-05 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
US11363975B2 (en) | 2005-11-01 | 2022-06-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8915850B2 (en) | 2005-11-01 | 2014-12-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10952652B2 (en) | 2005-11-01 | 2021-03-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9078607B2 (en) | 2005-11-01 | 2015-07-14 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11911151B1 (en) | 2005-11-01 | 2024-02-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11399748B2 (en) | 2005-11-01 | 2022-08-02 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10201301B2 (en) | 2005-11-01 | 2019-02-12 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11103165B2 (en) | 2005-11-01 | 2021-08-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9326716B2 (en) | 2005-11-01 | 2016-05-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8920319B2 (en) | 2005-11-01 | 2014-12-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10231654B2 (en) | 2005-11-01 | 2019-03-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11272867B2 (en) | 2005-11-01 | 2022-03-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9669162B2 (en) | 2005-11-04 | 2017-06-06 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US8585591B2 (en) | 2005-11-04 | 2013-11-19 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US11538580B2 (en) | 2005-11-04 | 2022-12-27 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US9323898B2 (en) | 2005-11-04 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US9332933B2 (en) | 2005-12-28 | 2016-05-10 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US10307091B2 (en) | 2005-12-28 | 2019-06-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US9795331B2 (en) | 2005-12-28 | 2017-10-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US8852101B2 (en) | 2005-12-28 | 2014-10-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US8545403B2 (en) | 2005-12-28 | 2013-10-01 | Abbott Diabetes Care Inc. | Medical device insertion |
USD961778S1 (en) | 2006-02-28 | 2022-08-23 | Abbott Diabetes Care Inc. | Analyte sensor device |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US9039975B2 (en) | 2006-03-31 | 2015-05-26 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US9625413B2 (en) | 2006-03-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8597575B2 (en) | 2006-03-31 | 2013-12-03 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US10028680B2 (en) | 2006-04-28 | 2018-07-24 | Abbott Diabetes Care Inc. | Introducer assembly and methods of use |
US10736547B2 (en) | 2006-04-28 | 2020-08-11 | Abbott Diabetes Care Inc. | Introducer assembly and methods of use |
US7920907B2 (en) | 2006-06-07 | 2011-04-05 | Abbott Diabetes Care Inc. | Analyte monitoring system and method |
US9808186B2 (en) | 2006-09-10 | 2017-11-07 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US8862198B2 (en) | 2006-09-10 | 2014-10-14 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US10362972B2 (en) | 2006-09-10 | 2019-07-30 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US11234621B2 (en) | 2006-10-23 | 2022-02-01 | Abbott Diabetes Care Inc. | Sensor insertion devices and methods of use |
US11724029B2 (en) | 2006-10-23 | 2023-08-15 | Abbott Diabetes Care Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US10070810B2 (en) | 2006-10-23 | 2018-09-11 | Abbott Diabetes Care Inc. | Sensor insertion devices and methods of use |
US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
US10363363B2 (en) | 2006-10-23 | 2019-07-30 | Abbott Diabetes Care Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US9095290B2 (en) | 2007-03-01 | 2015-08-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US9801545B2 (en) | 2007-03-01 | 2017-10-31 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US9314198B2 (en) | 2007-05-08 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US11696684B2 (en) | 2007-05-08 | 2023-07-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9035767B2 (en) | 2007-05-08 | 2015-05-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8362904B2 (en) | 2007-05-08 | 2013-01-29 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US20080281171A1 (en) * | 2007-05-08 | 2008-11-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and methods |
US9649057B2 (en) | 2007-05-08 | 2017-05-16 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10178954B2 (en) | 2007-05-08 | 2019-01-15 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8593287B2 (en) | 2007-05-08 | 2013-11-26 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9574914B2 (en) | 2007-05-08 | 2017-02-21 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8149117B2 (en) | 2007-05-08 | 2012-04-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10653317B2 (en) | 2007-05-08 | 2020-05-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9949678B2 (en) | 2007-05-08 | 2018-04-24 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US10952611B2 (en) | 2007-05-08 | 2021-03-23 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9177456B2 (en) | 2007-05-08 | 2015-11-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9000929B2 (en) | 2007-05-08 | 2015-04-07 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10848882B2 (en) | 2007-05-24 | 2020-11-24 | Cochlear Limited | Implant abutment |
US8613703B2 (en) | 2007-05-31 | 2013-12-24 | Abbott Diabetes Care Inc. | Insertion devices and methods |
US7609061B2 (en) | 2007-07-13 | 2009-10-27 | Med-El Elektromedizinische Geraete Gmbh | Demagnetized implant for magnetic resonance imaging |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US9066709B2 (en) | 2009-01-29 | 2015-06-30 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US8676513B2 (en) | 2009-01-29 | 2014-03-18 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US8473220B2 (en) | 2009-01-29 | 2013-06-25 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
USD957642S1 (en) | 2009-02-03 | 2022-07-12 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
US11213229B2 (en) | 2009-02-03 | 2022-01-04 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11166656B2 (en) | 2009-02-03 | 2021-11-09 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
USD957643S1 (en) | 2009-02-03 | 2022-07-12 | Abbott Diabetes Care Inc. | Analyte sensor device |
US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11202591B2 (en) | 2009-02-03 | 2021-12-21 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US9636068B2 (en) | 2009-02-03 | 2017-05-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US9993188B2 (en) | 2009-02-03 | 2018-06-12 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006871B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006870B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006872B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
USD882432S1 (en) | 2009-02-03 | 2020-04-28 | Abbott Diabetes Care Inc. | Analyte sensor on body unit |
USD955599S1 (en) | 2009-02-03 | 2022-06-21 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
US10786190B2 (en) | 2009-02-03 | 2020-09-29 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US8639353B2 (en) | 2009-04-23 | 2014-01-28 | Centre Hospitalier Universitaire De Rouen | Electrical connection device implantable in the human body |
US8545261B2 (en) | 2009-04-23 | 2013-10-01 | Centre Hospitalier Universitaire De Rouen | Electrical connection system between an electrical implanted medical device |
US8545255B2 (en) | 2009-04-23 | 2013-10-01 | Centre Hospitalier Universitaire De Rouen | Subcutaneous device for electrical percutaneous connection |
FR2944920A1 (en) * | 2009-04-23 | 2010-10-29 | Pierre Sabin | SUBCUTANEOUS PERCUTANEOUS ELECTRICAL CONNECTION DEVICE |
CN102428613B (en) * | 2009-04-23 | 2014-09-10 | 鲁昂大学医学中心 | Subcutaneous device for electrical percutaneous connection |
CN102428613A (en) * | 2009-04-23 | 2012-04-25 | 鲁昂大学医学中心 | Subcutaneous device for electrical percutaneous connection |
WO2010122142A1 (en) * | 2009-04-23 | 2010-10-28 | Centre Hospitalier Universitaire De Rouen | Subcutaneous device for electrical percutaneous connection |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
US11872370B2 (en) | 2009-05-29 | 2024-01-16 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US20110022120A1 (en) * | 2009-07-22 | 2011-01-27 | Vibrant Med-El Hearing Technology Gmbh | Magnetic Attachment Arrangement for Implantable Device |
US8774930B2 (en) | 2009-07-22 | 2014-07-08 | Vibrant Med-El Hearing Technology Gmbh | Electromagnetic bone conduction hearing device |
US11150145B2 (en) | 2009-08-31 | 2021-10-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
USD962446S1 (en) | 2009-08-31 | 2022-08-30 | Abbott Diabetes Care, Inc. | Analyte sensor device |
US11635332B2 (en) | 2009-08-31 | 2023-04-25 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US9968302B2 (en) | 2009-08-31 | 2018-05-15 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US10429250B2 (en) | 2009-08-31 | 2019-10-01 | Abbott Diabetes Care, Inc. | Analyte monitoring system and methods for managing power and noise |
US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US11045147B2 (en) | 2009-08-31 | 2021-06-29 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US10349874B2 (en) | 2009-09-29 | 2019-07-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
US9750439B2 (en) | 2009-09-29 | 2017-09-05 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
US9320461B2 (en) | 2009-09-29 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
US10765351B2 (en) | 2009-09-30 | 2020-09-08 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US9351669B2 (en) | 2009-09-30 | 2016-05-31 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US11259725B2 (en) | 2009-09-30 | 2022-03-01 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US9750444B2 (en) | 2009-09-30 | 2017-09-05 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
USD924406S1 (en) | 2010-02-01 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
US11064922B1 (en) | 2010-03-24 | 2021-07-20 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US11058334B1 (en) | 2010-03-24 | 2021-07-13 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US11000216B2 (en) | 2010-03-24 | 2021-05-11 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US10292632B2 (en) | 2010-03-24 | 2019-05-21 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US10952657B2 (en) | 2010-03-24 | 2021-03-23 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
USD987830S1 (en) | 2010-03-24 | 2023-05-30 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
US11266335B2 (en) | 2010-03-24 | 2022-03-08 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US10959654B2 (en) | 2010-03-24 | 2021-03-30 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US9265453B2 (en) | 2010-03-24 | 2016-02-23 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US9215992B2 (en) | 2010-03-24 | 2015-12-22 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US9687183B2 (en) | 2010-03-24 | 2017-06-27 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US10881341B1 (en) | 2010-03-24 | 2021-01-05 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US10010280B2 (en) | 2010-03-24 | 2018-07-03 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US11246519B2 (en) | 2010-03-24 | 2022-02-15 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
USD948722S1 (en) | 2010-03-24 | 2022-04-12 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
US8764657B2 (en) | 2010-03-24 | 2014-07-01 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
USD997362S1 (en) | 2010-03-24 | 2023-08-29 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
US10945649B2 (en) | 2010-03-24 | 2021-03-16 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US10881340B2 (en) | 2010-03-24 | 2021-01-05 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US9186098B2 (en) | 2010-03-24 | 2015-11-17 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US11013440B2 (en) | 2010-03-24 | 2021-05-25 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US10772547B1 (en) | 2010-03-24 | 2020-09-15 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US9572534B2 (en) | 2010-06-29 | 2017-02-21 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US10959653B2 (en) | 2010-06-29 | 2021-03-30 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US10973449B2 (en) | 2010-06-29 | 2021-04-13 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US10966644B2 (en) | 2010-06-29 | 2021-04-06 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US11064921B2 (en) | 2010-06-29 | 2021-07-20 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US10874338B2 (en) | 2010-06-29 | 2020-12-29 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US9743862B2 (en) | 2011-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Systems and methods for transcutaneously implanting medical devices |
US9308303B2 (en) | 2011-07-11 | 2016-04-12 | Vascor, Inc. | Transcutaneous power transmission and communication for implanted heart assist and other devices |
US8764621B2 (en) | 2011-07-11 | 2014-07-01 | Vascor, Inc. | Transcutaneous power transmission and communication for implanted heart assist and other devices |
US9980669B2 (en) | 2011-11-07 | 2018-05-29 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US9119010B2 (en) | 2011-12-09 | 2015-08-25 | Sophono, Inc. | Implantable sound transmission device for magnetic hearing aid, and corresponding systems, devices and components |
US9526810B2 (en) | 2011-12-09 | 2016-12-27 | Sophono, Inc. | Systems, devices, components and methods for improved acoustic coupling between a bone conduction hearing device and a patient's head or skull |
US9179228B2 (en) | 2011-12-09 | 2015-11-03 | Sophono, Inc. | Systems devices, components and methods for providing acoustic isolation between microphones and transducers in bone conduction magnetic hearing aids |
US9258656B2 (en) | 2011-12-09 | 2016-02-09 | Sophono, Inc. | Sound acquisition and analysis systems, devices and components for magnetic hearing aids |
USD915602S1 (en) | 2011-12-11 | 2021-04-06 | Abbott Diabetes Care Inc. | Analyte sensor device |
US9402570B2 (en) | 2011-12-11 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
US11179068B2 (en) | 2011-12-11 | 2021-11-23 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
US11051724B2 (en) | 2011-12-11 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
US11051725B2 (en) | 2011-12-11 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
USD915601S1 (en) | 2011-12-11 | 2021-04-06 | Abbott Diabetes Care Inc. | Analyte sensor device |
US9931066B2 (en) | 2011-12-11 | 2018-04-03 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
USD903877S1 (en) | 2011-12-11 | 2020-12-01 | Abbott Diabetes Care Inc. | Analyte sensor device |
US9693713B2 (en) | 2011-12-11 | 2017-07-04 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
US8897475B2 (en) | 2011-12-22 | 2014-11-25 | Vibrant Med-El Hearing Technology Gmbh | Magnet arrangement for bone conduction hearing implant |
US9420388B2 (en) | 2012-07-09 | 2016-08-16 | Med-El Elektromedizinische Geraete Gmbh | Electromagnetic bone conduction hearing device |
US9615181B2 (en) | 2012-07-09 | 2017-04-04 | Med-El Elektromedizinische Geraete Gmbh | Symmetric magnet arrangement for medical implants |
US9210521B2 (en) | 2012-07-16 | 2015-12-08 | Sophono, Inc. | Abutment attachment systems, mechanisms, devices, components and methods for bone conduction hearing aids |
US9736601B2 (en) | 2012-07-16 | 2017-08-15 | Sophono, Inc. | Adjustable magnetic systems, devices, components and methods for bone conduction hearing aids |
US9788125B2 (en) | 2012-07-16 | 2017-10-10 | Sophono, Inc. | Systems, devices, components and methods for providing acoustic isolation between microphones and transducers in bone conduction magnetic hearing aids |
US9022917B2 (en) | 2012-07-16 | 2015-05-05 | Sophono, Inc. | Magnetic spacer systems, devices, components and methods for bone conduction hearing aids |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US11612363B2 (en) | 2012-09-17 | 2023-03-28 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
USD980986S1 (en) | 2015-05-14 | 2023-03-14 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
US10674944B2 (en) | 2015-05-14 | 2020-06-09 | Abbott Diabetes Care Inc. | Compact medical device inserters and related systems and methods |
US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
US10300276B2 (en) | 2015-05-28 | 2019-05-28 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US10130807B2 (en) | 2015-06-12 | 2018-11-20 | Cochlear Limited | Magnet management MRI compatibility |
US11792587B1 (en) | 2015-06-26 | 2023-10-17 | Cochlear Limited | Magnetic retention device |
US10917730B2 (en) | 2015-09-14 | 2021-02-09 | Cochlear Limited | Retention magnet system for medical device |
US11792586B2 (en) | 2015-09-14 | 2023-10-17 | Cochlear Limited | Retention magnet system for medical device |
US10806936B2 (en) | 2015-11-20 | 2020-10-20 | Advanced Bionics Ag | Cochlear implants and magnets for use with same |
US11476025B2 (en) | 2015-12-18 | 2022-10-18 | Advanced Bionics Ag | MRI-compatible magnet apparatus |
US10463849B2 (en) | 2015-12-18 | 2019-11-05 | Advanced Bionics Ag | MRI-compatible magnet apparatus and associated methods |
US10532209B2 (en) | 2015-12-18 | 2020-01-14 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US10821279B2 (en) | 2015-12-18 | 2020-11-03 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US9919154B2 (en) | 2015-12-18 | 2018-03-20 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US10576276B2 (en) | 2016-04-29 | 2020-03-03 | Cochlear Limited | Implanted magnet management in the face of external magnetic fields |
US10646718B2 (en) | 2016-11-15 | 2020-05-12 | Advanced Bionics Ag | Cochlear implants and magnets for use with same |
US11595768B2 (en) | 2016-12-02 | 2023-02-28 | Cochlear Limited | Retention force increasing components |
US11071478B2 (en) | 2017-01-23 | 2021-07-27 | Abbott Diabetes Care Inc. | Systems, devices and methods for analyte sensor insertion |
US11097095B2 (en) | 2017-04-11 | 2021-08-24 | Advanced Bionics Ag | Cochlear implants, magnets for use with same and magnet retrofit methods |
US11779754B2 (en) | 2017-04-11 | 2023-10-10 | Advanced Bionics Ag | Cochlear implants, magnets for use with same and magnet retrofit methods |
US11752338B2 (en) | 2017-04-25 | 2023-09-12 | Advanced Bionics Ag | Cochlear implants having impact resistant MRI-compatible magnet apparatus |
US11364384B2 (en) | 2017-04-25 | 2022-06-21 | Advanced Bionics Ag | Cochlear implants having impact resistant MRI-compatible magnet apparatus |
US11287495B2 (en) | 2017-05-22 | 2022-03-29 | Advanced Bionics Ag | Methods and apparatus for use with cochlear implants having magnet apparatus with magnetic material particles |
US20220176111A1 (en) * | 2017-08-02 | 2022-06-09 | Med-El Elektromedizinische Geraete Gmbh | MRI-Safe and Force-Optimized Implantable Ring Magnet System with an Enhanced Inductive Link |
EP3641880A4 (en) * | 2017-08-02 | 2020-05-27 | MED-EL Elektromedizinische Geraete GmbH | Mri-safe and force-optimized implantable ring magnet system with an enhanced inductive link |
CN110944715B (en) * | 2017-08-02 | 2023-07-07 | Med-El电气医疗器械有限公司 | Implantable ring magnet system |
US11660447B2 (en) * | 2017-08-02 | 2023-05-30 | Med-El Elektromedizinische Geraete Gmbh | MRI-safe and force-optimized implantable ring magnet system with an enhanced inductive link |
CN110944715A (en) * | 2017-08-02 | 2020-03-31 | Med-El电气医疗器械有限公司 | MRI safe and force optimized implantable ring magnet system with enhanced inductive link |
US10646712B2 (en) | 2017-09-13 | 2020-05-12 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus |
US11471679B2 (en) | 2017-10-26 | 2022-10-18 | Advanced Bionics Ag | Headpieces and implantable cochlear stimulation systems including the same |
US11638823B2 (en) | 2018-02-15 | 2023-05-02 | Advanced Bionics Ag | Headpieces and implantable cochlear stimulation systems including the same |
USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
USD1006235S1 (en) | 2020-12-21 | 2023-11-28 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
USD982762S1 (en) | 2020-12-21 | 2023-04-04 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
US11918808B2 (en) | 2022-12-01 | 2024-03-05 | Cochlear Limited | Magnet management MRI compatibility |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USRE32947E (en) | Magnetic transcutaneous mount for external device of an associated implant | |
US4352960A (en) | Magnetic transcutaneous mount for external device of an associated implant | |
US20220021991A1 (en) | Bone conduction magnetic retention system | |
US10880662B2 (en) | Retention magnet system for medical device | |
EP2679025B1 (en) | Mri safe actuator for implantable floating mass transducer | |
US6178353B1 (en) | Laminated magnet keeper for implant device | |
CA1301254C (en) | Adjustable magnetic supercutaneous device and transcutaneous coupling apparatus | |
US5217011A (en) | Method and apparatus for transdermal communication | |
US10321247B2 (en) | External component with inductance and mechanical vibratory functionality | |
US10674287B2 (en) | Magnet placement and antenna placement of an implant | |
US5558618A (en) | Semi-implantable middle ear hearing device | |
WO1996025832A1 (en) | Failure detection in auditory response stimulators | |
US20130035540A1 (en) | Electromagnetic Bone Conduction Hearing Device | |
US20210093861A1 (en) | Monolithic component for an implantable medical device | |
US10893937B2 (en) | Magnet support of an implant | |
WO2003092326A1 (en) | Mri-compatible cochlear implant | |
CN110650769B (en) | Particle alignment method and particle alignment indication kit | |
Hough et al. | A middle ear implantable hearing device for controlled amplification of sound in the human: a preliminary report | |
EP4215240A1 (en) | Multipole magnet for medical implant system | |
EP2892609B1 (en) | Electromagnetic bone conduction hearing device | |
AU2016323458B2 (en) | Bone conduction transducer system with adjustable retention force | |
US11272299B2 (en) | Battery positioning in an external device | |
Dormer et al. | The cochlear implant (auditory prosthesis) utilizing rare earth magnets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: INTEGRIS BAPTIST MEDICAL CENTER, INC., OKLAHOMA Free format text: CHANGE OF NAME;ASSIGNOR:BAPTIST MEDICAL CENTER OF OKLAHOMA, INC.;REEL/FRAME:007795/0012 Effective date: 19951218 |